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ABSTRACT
THINKING BEYOND HEALTH TO MOTIVATE DIETARY CHANGE FOR OBESITY MANAGEMENT
Mark Berman, Robert Baron†, Ruth Marlin¥, Kuo-Chiang Lian†, Christine Chi¥, and Dean Ornish†¥.
†

Department of Internal Medicine, University of California, San Francisco (UCSF), CA and

¥

The

Preventive Medicine Research Institute, Sausalito, CA. (Sponsored by David Katz, Department of
Epidemiology & Public Health, Yale University School of Medicine, New Haven, CT.)

T

his pilot study assessed the feasibility, acceptability and efficacy of a novel approach to facilitating
dietary change and weight loss in obese adults by presenting vegan environmental, health and

farm animal treatment information in a 6 week, group-based, educational nutrition program (called a
“vegan healthy eating program”). Twenty-nine (29) medically stable, obese adults were recruited from 3
ambulatory care clinics at UCSF and enrolled using partial randomization into one of two serially
occurring intervention groups (Group 1 n=14, followed by Group 2 n=15). A delayed intervention control
group (n=9) was used, consisting of participants enrolled in Group 2 who were available for collection of
baseline measures prior to the start of Group 1’s intervention. All intervention participants provided data
immediately following their vegan healthy eating program (2 months post baseline) and again at 3 and 9
months post baseline. 10% of initial contacts (29 patients) met inclusion and exclusion criteria and were
enrolled; 25 participants were retained at 3 months, 20 at 9 months. Mean intervention session
satisfaction as measured by anonymous surveys using a 1-7 Likert scale (1=extremely unsatisfied,
7=extremely satisfied) was 6.2 (SD=1.1). Statistically significant reductions in calories from animal
products, percent fat, cholesterol and increases in the recommended food score, fruits and vegetable
servings were observed within the intervention group only, at all timepoints. Mean weight change was
+2.8 lbs (3.0, n=8, p=0.035) in control participants after 4.3 weeks, and -3.4 lbs (5.0, n=25, p=0.002), -5.9
lbs (7.7, n=25, p=0.001), and -8.8 lbs (14.2, n=20, p=0.012) after 7.3, 15.6 and 41.7 weeks in intervention
participants, respectively. In conclusion, this vegan healthy eating program demonstrated good feasibility,
high satisfaction, and facilitated a shift towards a plant-based diet and modest, progressive short-term
weight loss among intervention participants.

ii

ACKNOWLEDGEMENTS
This thesis was made possible by the invaluable assistance, support and generosity of
numerous people. The following individuals made noteworthy contributions to this work.
Co-investigators
The study outlined in this thesis could not have been completed without the invaluable
contributions of the co-investigators: Robert Baron, Ruth Marlin, Christine Chi, Kuo-Chiang
Lian, and Dean Ornish. In particular, Christine and Kuo each put tremendous energy and effort
into innumerable aspects of this study.
Mentors
Without the selfless mentorship provided by the following four physicians, my interest in
research might not have developed and this project certainly would not have come to fruition.
Ruth Marlin provided tireless mentorship and invaluable support throughout every phase of this
project. Her enthusiasm, unshakeable faith, and dedication to mentoring enabled me to overcome
the barriers inherent to clinical research. Robert Baron generously acted as the attending
physician for this study and provided thoughtful and patient guidance at critical points in the
study’s design and execution. Dean Ornish’s research paved the way for the research line
initiated by this study (and, of course, countless other research paths). He was a constant source
of inspiration, support and guidance. David Katz has been a pivotal mentor of mine since the
beginning of medical school. His wisdom and compassion inspired my interest in the study of
dietary behavior change. His experience, clinical and research skills and knowledge in nutrition,
obesity, behavior change, and clinical research design were invaluable throughout this project.
Consultants
Numerous experts were called upon for technical assistance throughout this project. Most
important were: David Katz (and the Yale-Griffin Prevention Research Center) and Neal Barnard
(and the Physician’s Committee for Responsible Medicine) for clinical research design
assistance; Chuck McCulloch and Valentine Njike for hours of assistance with biostatistics;

iii
Michael Kohn for patiently providing data management advice and technical assistance; Trish
Painter, Marta Van Loan, and Linda Frassetto for helpful consultation regarding DEXA Scans
and RT3 Activity Monitors.

Support
This research was made possible by a clinical research fellowship from the Doris Duke
Charitable Foundation and the University of California, San Francisco, directed by Joel Palefsky.
Invaluable support was also generously given by Joel Palefsky (and members of the GCRC
advisory committee); Patty McCormac, Dennis Malone, Gerdi Weidner, Elaine Pettengill and the
other staff and volunteers of the Preventive Medicine Research Institute. John Forrest and the
Yale School of Medicine were also instrumental in encouraging and facilitating the initiation of
this research.

Clinical Referrers
This research would not have been feasible without the invaluable help from the following UCSF
clinical referrers: David Besio (and the UCSF Weight Management and Risk Reduction
Program), Karen Bagatelos (and the UCSF Gastroenterology Clinic), Marlene Bedrich, Umesh
Masharani (and the UCSF Diabetes Clinic), Kellie Sheehan, and Marta Cavasoz. Members of the
UCSF Department of Nutrition were also of great support.

Intervention Development & Execution
Developing an intervention from scratch was an enormous task made extraordinarily easier
thanks to the expertise and generosity of Stacey Dunn-Emke, Linda Riebel, John Robbins,
Michele Simon, Ruth Marlin, and Robert Baron – all of whom made valuable contributions to
the intervention through their guest lectures. In addition, Cynthia Lauron and Karen Todd
directed efforts by the GCRC Metabolic Kitchen staff who patiently prepared low-fat, vegan
meals and snacks for our participants – an enormous feat that enabled the intervention and data
collection to proceed.

iv
Research assistance
Data collected depended on generous assistance from the UCSF GCRC research nursing team
for general data collection and John Duda for graciously performing all DEXA scans.

Volunteers
Several volunteers made important contributions to this study: Gabe Quash provided excellent,
and time intensive videographical assistance; Olive Lin assisted tremendously with data entry
and preliminary dietary analysis; Alejandra Diaz and Katy Rivlin provided timely, extremely
helpful and important assistance with literature reviews, reference management and word
processing and thus enabled completion of this project.

Research Participants
Without the generous involvement of research participants no clinical research could take place.
I am especially grateful to our participants for their willingness to participate in an unusual pilot
trial, and for their eagerness to contribute to science for both the betterment of others and also for
my development as a both a clinician and researcher. I learned a tremendous amount from their
struggle, their wisdom and their compassion.

Finally, none of this would have come to fruition without the loving support and guidance
from my parents, brother and dear friends and family.

v

TABLE OF CONTENTS
Abstract

i

Acknowledgements
Table of Contents
Background & Significance
Obesity – prevalence
Obesity – etiology
Obesity – mortality, morbidity, costs
Obesity – clinical treatment & maintenance of weight loss
Diet & disease
Shifting patients to a plant-based diet
Motivation for dietary adherence in vegetarians
Dietary adherence – theory
Dietary behavior change
Preliminary studies
Summary of background & significance
Purpose
Specific Aims
Hypothesis
Methods
Results
Discussion
Appendixes
Recruitment Pamphlet
Consent Form
Block Food Categories
VHEP Behavioral Survey
Relational Database Layout
VHEP Curriculum Overview
References

ii
v
1
2
5
7
10
15
16
17
19
22
23
24
25
26
43
68
87
89
94
95
106
107
114

A note from the author:
The thesis proposed in the following pages is a description and examination of a clinical trial
designed and carried out by the author at the University of California, San Francisco from July
2002 through to December 2003. Thus references to this thesis will often be listed as “this
study”.
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BACKGROUND & SIGNIFICANCE
The global obesityi epidemic: prevalence
The epidemic of obesity is no longer restricted to affluent western nations. Indeed, data from
every region of the world clearly indicates that we are in the midst of a global obesity epidemic.1
The World Health Organization has estimated that over one billion adults worldwide are
overweight, of which at least 300 million are obese.2 Current prevalence statistics are alarming
and appear to be worsening in virtuallyii every nation.1
In the US, age-adjusted obesity prevalence among adults increased from 14.5% in 1971-74 to
22.9% in 1988-94 to 30.5% in 1999-2000. This trend stems from an increase in body mass index
(BMI) in all age-gender-race groups.3 Similar trends are evident in other industrialized countries,
where prevalence estimates currently range between 14 and 20%.4 For example, in the majority
of European countries, obesity prevalence has increased by 10-40% in the past 10 years.1
A rapid increase in obesity is also evident in developing nations, although data from these
countries is more limited. In urban China, for example, childhood obesity prevalence increased
from 1.5% in 1989 to 12.6% in 1997. Similarly, the prevalence of overweight increased from
14.6 to 28.9% during the same period. The rate of increase of BMI among Chinese children has
been calculated as 0.2 kg/m2 per year in urban areas and 0.1 kg/m2 per year in rural areas.5

i

Obesity, among adults, is defined by the Body Mass Index (BMI) – a ratio of weight to height squared (in metric
units) – with a BMI of 25.0 kg/m2 or greater defining overweight and 30.0 kg/m2 defining obesity. Please see
footnote iii related to this definition.
ii
The possible exception is among women in some Scandinavian countries, whose obesity prevalence may be
stabilizing.1
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Contrary to the perception that obesity is a disease of affluence, obesity is now strongly
associated with poverty around the globe.6 And for the first time in history, several developing
nations have a similarly high prevalence of both underweight or under-nourished people and
overweight or obese people.1

The global obesity epidemic: etiology
Although genetics play an important role in the etiology of weight gain and obesity, diet and
activity patterns are more significant contributors to the current obesity epidemic.7, 8 Support for
this conclusion stems from the dramatic, consistent and steady rise in obesity prevalence in the
last two to three decades, during which significant changes in the global gene pool are highly
unlikely. Furthermore, these population-based changes have correlated with measurable and
putative environmental changes. In the US, for example, the rise in obesity has coincided with a
steady increase in portion sizes,9 total food consumption,10 and total caloric intake.11 Increases in
sedentary behavior have also had a dramatic impact,12 especially in UK where obesity prevalence
has doubled in the last 10 years.13 However, in the US, prevalence of individuals with no leisuretime physical activity (a measure of sedentary behavior) appears to have peaked in 1996 and has
since declined while obesity has increased.14 This suggests that no leisure-time physical activity
trends do not fully capture energy expenditure trends and/or that decreases in sedentary behavior
in recent years have not been able to compensate for increasing caloric intake.
Thus, a relatively simplistic model of energy expenditure (i.e. weight gain is a function of an
increase in energy intake and/or a decrease in energy expenditure) suffices to explain much of
modern day obesity. However, the factors leading to this energy expenditure imbalance on both
individual and population levels are complex, numerous and often contentious. The so-called
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‘environmental’ contributors include a host of factors almost too long to list. Among them are
political and economic forces (federally supported agricultural subsidies, corporate marketing
practices, increasing access to high calorie foods, national school lunch programs, decreasing
resources for school physical education programs, etc.), cultural forces (decreases in breast
feeding, the high status associated with overweight in several developing nations, etc.),
technological forces (increased car ownership, continuing introduction of energy-saving devices
and technologies into work, school and home environments, etc.), popular nutritional beliefs and
weight

management

practices

(yo-yo

dieting,

national

food

pyramids,

widespread

misconceptions about nutrition, popular diet books, etc.), etc., etc. Weighing the relative impact
of each of these environmental factors is important when considering public health initiatives to
prevent and treat obesity, but is beyond the scope of this thesis.
As previously discussed, the laws of thermodynamics dictate that weight gain is the direct result
of specific behaviors that lead to changes in dietary intake and/or activity. The genetic and epigenetic determinants of these behaviors and of weight gain are considerably complex and have
vast implications for the future of obesity treatment and prevention.15 Despite the complexities,
the discovery of numerous genes and gene-products that favor weight gain is consistent with and
can be predicted by our current understanding of evolution and physiology. As first suggested in
1962 by James Neel in his “thrifty gene hypothesis”,16 it is likely that our ancestors evolved
during lengthy periods of food scarcity, and thus an enhanced (and genetically based) ability to
conserve energy and accumulate fat stores would have conferred a significant survival advantage
during times of famine. Those ancestors possessing ‘thriftier’ genes would be more likely to
survive than those lacking ‘thrifty genes’ and would create offspring who would also possess and
pass on these ‘thrifty genes’, and so on. This teleological perspective suggests that, variations
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aside, a genetic predisposition to weight gain in times of food abundance is now widespread
among most if not all humans. Thus genetic traits that once conferred a significant advantage are
now disadvantageous in the modern environment.
Evidence for genetically controlled weight gain also comes from the observation that despite
infinite variations in intake and expenditure that occur over any period of time, the human body
is able to maintain a remarkably stable weight over a great length of time, under certain
conditions.17 This and other evidence suggest there is strong genetically based control of weight
and/or the behaviors that regulate weight. Collectively these observations suggest that
population-wide weight gain in inevitable as calorically-dense food becomes increasingly
available and that genetic factors may mediate this process.18 Indeed, this view is consistent with
global obesity trends which demonstrate rising obesity prevalence in concert with the global
spread of a “Western” or a food-abundant environment. However, the corollary of this argument
is that excessive weight gain only occurs in an environment that facilitates access to excessive
caloric intake. And since the environment is under some degree of conscious human control,
population-wide weight gain does not have to be an inevitability of modernization.
Ultimately, genetic and environmental explanations for the current obesity epidemic must
converge into a single model. In this vain, research examining the interaction between genetic
expression and environmental forces is furthering our understanding of obesity and will likely
lead to enhanced prevention and treatment strategies. The field of peri-natal programming, for
instance, has contributed strong evidence that factors such as maternal glycemic control,19 breast
feeding,20 and parental rearing strategies21, 22 have a significant influence on appetite, dietary and
activity patterns, and weight gain in childhood. This is important because childhood obesity is a
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strong predictor for adulthood obesity23 and because it suggests novel approaches for obesity
prevention.

In summary, the high prevalence of obesity can be attributed mostly to environmental forces that
have led to both increasing caloric intake and decreasing caloric expenditure. The obesity
epidemic is a result of a worsening population-wide energy imbalance acting on a highly
prevalent genetic predisposition to weight gain. Our evolving understanding of the etiology of
the current obesity epidemic suggests many potential interventions for both the treatment and
prevention of obesity and its consequences.

Obesity: mortality, morbidity, and costs
Adulthood obesity and overweight are associated with significant decreases in life expectancy.24,
25

Data from Framingham, for example, suggests an average of 7 years of life lost to a 40 year-

old non-smoker with obesity.25 In fact, the rational for using the BMI to define obesity stems in
part from the observation that at a BMI of 30 kg/m2 risk of mortality increases by approximately
30% and continues to increase as BMI increases.26 At a BMI of 40 kg/m2 or more, for example,
risk of premature mortality increases by 100% or more.26 It is important to point out, however,
that the definition of obesity as a BMI ≥ 30 is generous, as the major morbidities associated with
obesity are linearly related to increasing BMI starting at a BMI of 19 or 20 kg/m2.27 Thus,
optimal life-expectancyiii in non-smoking adults is estimated to be most likely at a BMI of
approximated 20 kg/m2.6

iii

For this and other reasons some authors have suggested that a global definition of frank obesity of a BMI of 25
kg/m2 or greater may be more appropriate, with the upper limit of normal BMI being 22.9 kg/m2.6
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A conservative estimate suggests that mortality attributable to overweight in 2000 increased by
76.6% from 1991 and for the first time accounted for almost as many deaths as tobacco (385,000
vs. 435,000).28 Since a slight decline in smoking prevalence has been observed in this period and
tobacco related deaths did not change significantlyiv, linear extrapolation would predict that
overweight has or soon will overtake tobacco as the number one cause of death in the US. For
this reason, and the enormous contribution to morbidity (discussed below), some authors have
deemed obesity to be the number one public health problem in the US.25, 29
Morbidity (and death) from obesity stems primarily from its strong association with type 2
diabetes, cardiovascular disease, and certain cancers.30 Approximately 57% of type 2 diabetes,31
17% of cardiovascular disease31 and 14-20% of all cancers32 are attributable to obesity. Obesity
also contributes significantly to gallbladder disease, polycystic ovarian syndrome, gestational
diabetes, menses disorders and other gynecological conditions, osteoarthritis, obstructive sleep
apnea, amongst other medical conditions.29,

33

As expected, health related quality of life is

decreased in obesity.34 Obesity is also associated with significant social stigma and poor self
esteem.35 Furthermore, obese individuals suffer from discrimination,36 and economic
disadvantage.37
The economic impact of obesity is considerable. Annual healthcare costs attributable to obesity
are estimated to be $75 Billion38 to $100 Billion39 in 2003 dollars. At present, a conservative
estimate suggests that obesity accounts for 5.3% of total medical expenditures.38 The total cost

iv

The 1991 estimate by McGinnis and Foege of 400,000 deaths attributable did not include deaths to second-hand
smoke or maternal smoking. The estimate for the year 2000 by Mokdad et al did include these causes of death. They
estimated 435,000 deaths attributable to tobacco with 35,000 of these caused by second-hand smoke and 1,000 by
maternal smoking.28 Thus, it is reasonable to conclude that tobacco related deaths did not change significantly
between 1991 and 2000, or may even have declined slightly.
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to society is understandably difficult to calculate but can be assumed to be significantly greater
than the cost of healthcare expenses alone.

In summary, obesity confers a significantly increased risk for morbidity and premature mortality
and has important psychosocial ramifications. The economic costs attributable to obesity are
considerable. Given that obesity prevalence continues to rise, obesity can be considered the
number one public health problem in this country at least.

Obesity: clinical treatment & maintenance of weight loss
Overweight and obese individuals can gain significant benefits from modest weight loss.40 The
medical benefits of modest weight loss are well established and include clinically significant
improvements in blood pressure,41 glycemic control,42 cholesterol and other cardiovascular risk
factors.40, 43, 44 These benefits are likely a direct effect of weight loss and are independent (to a
degree) of the means of weight loss.
Advances in the clinical treatment of obesity have led to a variety of strategies including dietary,
behavioral, activity-focused, pharmacological and surgical approaches that have been successful
at inducing modest (5-10% of body weight) short-term weight loss.45 Neither the scientific nor
popular literature point to a single best approach to short-term weight loss. Rather, almost any
approach (assuming it favorably alters the ratio of calories in to calories out) can induce shortterm weight loss. Distinguishing between various approaches can be difficult, especially for the
lay population, and must take into account safety, sustainability, additional benefits, as well as
both short and long-term cost-efficacy. This is particularly important in light of the currently
held view that obesity is a chronic disease warranting chronic (long-term or lifelong) treatment.
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In contrast to short-term weight loss, long-term maintenance of weight loss in an environment
that promotes weight gain represents a considerable challenge.7 The data on success of long-term
(defined here broadly as 1 to 5 years), modest weight loss in structured university-based
programs presents a mixed picture. The proportion of a sample maintaining successful long-term
weight loss ranges from zero or near-zero46-48 to a more hopeful outlook of 13-53%.49-52 While
the latter may be more consistent with weight loss maintenance in non-academic settings (i.e. in
the general public),53 this still suggests that the majority of overweight and obese individuals do
not achieve these broad but modest definitions of successful long-term weight loss, in academic
weight management settings. Recently, however, Wing and Hill proposed a definition of longterm weight loss maintenance as intentionally losing 10% of initial body weight and keeping it
off for at least 1 year.52 This definition was proposed largely because of the established medical
benefits of losing 5-10% of body weight, but also in part because of the challenge inherent to
long-term weight loss maintenance. The authors felt that with this definition approximately 21%
of overweight/obese individuals could achieve successful long-term weight loss.52
The relative lack of success observed in obesity trials can not be blamed on lack of interest or
effort on the part of patients. In fact, the majority of obese Americans appear to be concerned
about being overweight as evidenced by observations from the CDC’s Behavioral Risk Factor
Surveillance System which found that 65.7% of obese adults claimed to be actively trying to lose
or maintain their weight.54
Despite the pessimism that pervades clinical obesity treatment, it is clear that some individuals
are able to successfully maintain modest, long-term weight loss. The National Weight Control
Registry was set up to study these successful weight loss maintainers. Three common factors
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have been identified as being common among these individuals: 1) eating a diet low in fat and
high in carbohydrates, 2) frequent self-monitoring and 3) regular exercise.52
With respect to clinical interventions aimed at the above mentioned behaviors, more intensive
and/or longer interventions generally produce more substantial results in both the short and longterm, as would be expected.45, 55, 56 Similarly, multi-disciplinary interventions are more likely to
produce more significant results than single component interventions. Still there is no consensus
that any one program or combination of interventions is more effective or cost-effective.57 For
this reason, along with the alarming trends in obesity prevalence there is a clear need for novel
strategies for assisting in long-term weight loss maintenance.52, 57
Of particular challenge and interest is the development and testing of novel strategies to assist
individuals in maintaining healthy dietary behavior change conducive of healthy weight loss or
weight maintenance.58 While it can be predicted that dietary interventions have greatest efficacy
when combined with other lifestyle modifications, there remains utility in testing stand-alone
dietary interventions for obesity management (as is done in this thesis). It must be stressed,
however, that the end goal of this line of research is not a stand-alone intervention but an
intervention that could be integrated into a comprehensive, multi-disciplinary obesity
treatment strategy. The added benefit of examining dietary change in an obese population is the
potential to apply the principles learned to other aspects of chronic disease prevention or
treatment.
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Diet and Disease: in relation to obesity and other chronic diseases
This study is designed to pilot a novel behavioral approach that could facilitate the maintenance
of weight loss in obese individuals by helping to initiate long-term dietary change. A key
premise of this study is that shifting to a plant-based diet will confer a breadth of health benefits
independent of benefits gained from facilitating improved weight management. The following
section provides a brief rational for this premise.
Although much remains unknown, the connection between diet and disease is strong and wellestablished. The combination of poor diet and physical inactivity accounted for at least 400,000
or 16.6% of all US deaths in 2000 (up from 300,000 or 14% in 1990).28 Extrapolating the trends
from this data (obtained from the Centers for Disease Control and Prevention) suggests that poor
diet and inactivity is or soon will be the number one cause of preventable death in the US. At
present, diet represents a modifiable risk factor for the top 3 causes of death (heart disease,
malignant neoplasm, cerebrovascular disease) which collectively account for approximately 1.4
million of the 2.4 million deaths each year.28
While even a cursory overview of the impact of diet on disease is beyond the scope of this thesis,
it is possible to highlight some relevant themes that evolve from the literature which support the
use of the proposed study intervention:
•

A distinction between foods of plant vs. animal origin, with foods derived from plants
conferring protection against several chronic diseases and those from animals
conferring added risk for several chronic diseases.59
o

There are several notable exceptions including fish oil, a source of omega-3 fatty acids,
which has been shown to reduce death from cardiac events;60,

61

hydrogenated
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vegetable oils, a source of trans-fats, and highly saturated vegetable oils (e.g. palm oil),
both of which are thought to promote cardiovascular disease62, 63 and type 2 diabetes.64
Similarly, it is also important to emphasize that plant-based diets by virtue of
minimizing animal products alone are not necessarily health-promoting. For example,
french-fries, soda, candy, refined pasta, and white rice are all plant-derived foods that
are more likely to promote than prevent chronic disease.65
o

However, several explanations have been proposed for the benefits attributed to many
plant-based dietary patterns, including high intake of various classes of plant-based
foods (e.g. fruits and vegetables, as discussed below), lower intake of total fat,
saturated fat, animal protein, heterocyclic amines and cholesterol and higher intake of
fiber, grains, legumes, magnesium, folate, boron and other trace minerals, vitamin C
and E and other antioxidants, carotenoids and other phytochemicals.66-68

•

Perhaps the most well established health benefits are those derived from the
consumption of whole fruits and vegetables. Fruit and vegetable intake has been
consistently associated with reduced risk for coronary artery disease,69-72 type 2 diabetes,73-75
stroke,76, 77 hypertension,78 cancer,79, 80 metabolic syndrome,81 and obesity.82

•

The benefits of whole grains and detriments of refined grains have been demonstrated
especially with regards to cardiovascular disease,83, 84and type 2 diabetes.85-87 Whole grains,
as well as other low-glycemic index foods also show promise in promoting weight loss.88-90

•

Nuts, olives and olive oil are thought to confer protection against cardiovascular
disease,91-93 and type 2 diabetes.94 However, given that nuts, seeds, olives and other oil rich
foods tend to be rich in calories because of their high fat content there is still uncertainty
over their role in diets designed for obese individuals.

12
•

Red meat has been consistently associated with increased risk of heart disease,95, 96 and
type 2 diabetes.97, 98 Red meat, especially well done meat and processed meat, contributes to
colorectal cancer,99-101 breast cancer,102, 103 lung cancer104, 105, pancreatic, renal and prostate
cancers.68 Several mechanisms have been proposed for this association, including the
formation of heterocyclic amines in well-done meat68, the high content of heme iron which
contributes to N-nitrosation,106, 107and the saturated animal fat content of meat.102
o

Given their relative similarities in biochemical composition, it is not clear why red
meat has a much stronger association with the above diseases than the so-called white
meats (chicken, pork, etc.). Several explanations exist, including differences in fatty
acid composition, heme content and other atherogenic or carcinogenic compounds. Or
perhaps more likely, this paradoxical association may be explained by the wellobserved co-segregation of white-meat consumption with a dietary pattern that
contains a high proportion of protective substances of plant-origin and lower
proportion of disease promoting substances of animal or plant-origin.108-111
Importantly, this protective or “prudent” dietary pattern is also associated with lower
rates of obesity.82, 112

•

The rearing of animals for food is increasingly being recognized as a major threat to
public health, mostly because of food safety issues pertaining to foodborne illnesses and
antibiotic resistance.
o

Foodborne

diseases

cause

approximately

76

million

illnesses,

325,000

hospitalizations, and 5,000 deaths in the United States each year.113 The USDA’s
Economic Research Service estimated the annual U.S. economic costs (including both
medical costs and indirect costs such as lost productivity) incurred for the major
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bacterial pathogens: Escherichia coli O157:H7 and other pathogenic E. Coli,
Campylobacter, Listeria monocytogenes, and Salmonella to be at least $6.9 billion in
2000 dollars.114 In addition to acute illness these bacteria are associated with several
chronic or sub-acute illnesses such as reactive arthritis, Guillain-barré syndrome, and
hemolytic uremia syndrome115
o

Importantly, the vast majority of foodborne illness stem from animal-agricultural
practices and the consumption of animal-products. For example, cases of Salmonella,
Listeria, and Toxoplasma are either traced to the consumption of animal products or
the use of animal manure, and account for more than 75% of deaths caused by known
pathogens.113

o

Historically, the majority (if not all) of the major infectious epidemics arose from
close contact with animals domesticated for food production or from close contact
with wild animals.116 Modern day diseases that stem from our dependency on
massive, centralized, confinement-rearing animal agriculture include SARS,117 the
Asian Bird Flu ,118, 119 and Bovine-Spongiform Encephalopathy.120

o

Of even greater public health concern is antibiotic resistance which stems from
inappropriate use or overuse of antibiotics. Approximately 50% of antibiotics are
used in non-human animals mostly for sub-therapeutic uses such as growth promotion
of livestock.121 The combination of over-crowded conditions for farm animals, the
overuse and improper use of antibiotics in animal agriculture, the use of antibiotics
used to treat human disease in agriculture, the fact that many pathogenic bacteria can
infect both humans and other animals, and contact between humans and farm animals
or animal-products, makes the generation of multi-drug resistant pathogenic bacteria
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inevitable. An example of such a phenomenon is the rapid emergence of Salmonella
DT104 resistant to Ampicillin, Chloramphenicol, Streptomycin, Sulfonamides, and
Tetracycline. Prevalence of multi-drug resistant DT104 increased from less than one
percent in 1979 to 34% in 1996 and has been linked to the heavy use of these
antibiotics in the rearing of cattle and other livestock.122, 123 Antibiotic resistant strains
of Salmonella are now commonly isolated in retail ground meats, with some strains
resistant to 12 antibiotics.123

Several other themes important to this thesis remain controversial. For example, there is great
debate over the ideal proportion of fat intake in an obese population.124 Similarly, it is unclear
whether animal protein is an independent risk factor for chronic disease and thus there is not
consensus as to the need to independently reduce or eliminate it from the diet. Certainly, the
evolving role for animal protein as a causative agent in osteoporosis, renal disease and
hypertension deserves careful consideration.125 Nonetheless, there is agreement among most
nutrition experts that shifting to a plant-based diet would confer both clinical and public
health benefitsv. The optimal degree of “shift” and the means to accomplish this
challenging goal are important and under-explored areas of research.

v

For example, the U.S. Department of Health and Human Services’ established the Healthy People 2010 nutritional
goals in order to “Promote health and reduce chronic disease associated with diet and weight”. These goals aim to:
increase fruit, vegetable, and grain consumption; increase worksites that offer nutrition or weight management
classes and physician counseling on diet and nutrition; and to reduce fat and saturated fat consumption and
weight/BMI. While some progress has been made in recent years, there remains considerable disparity between
current national dietary patterns and these goals. Moreover, for some goals, such as reducing BMI, recent data
demonstrates trends away from targets.50 Thus, shifting the population towards a plant-based dietary pattern
represents an important but substantial challenge.
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Shifting patients to plant-based diet: a novel approach
This study aims to pilot a novel approach to shifting obese patients to a plant-based diet. The
study intervention is based on behavioral motivators that enable vegetarianvi and vegan
individuals to initiate and maintain strict dietary change. Vegetarians (and vegans) represent an
ideal population from whom to draw novel dietary and weight management strategies for reasons
pertaining to both the dietary pattern itself and the psychology that often accompanies it:
•

Compared to non-vegetarians, vegetarians have lower Body Mass Indexes (BMIs), lower
rates of obesity and eat more complex carbohydrates and fiber but less animal fat and
alcohol.126-128

•

A vegetarian dietary pattern, particularly a low-to-moderate fat, whole-food, vegetarian diet,
has been associated with reduced risk of several chronic diseases, including hypertension,
hyperlipidemia and coronary artery disease (CAD),95, 129-132 stroke,133 type 2 diabetes,98, 130
and several cancers.80, 134

•

Randomized controlled trials have employed these dietary patterns (usually in concert with
other lifestyle modifications) to demonstrate reversal of heart disease,135-138 prevention and
treatment of type 2 Diabetes,56, 139-144 reductions in hypertension,145 hyperlipidemia,136, 137,
146, 147

•

and weight.136, 137, 142

Observational data suggests that self-selected vegetarian diets tend to be particularly longlived.148,

149

This is important as an efficacious but unsustainable diet would not be an

appropriate model for long-term dietary change interventions.

vi

Similar to the term “plant-based diets”, the terms vegetarian (a diet devoid of animal flesh but that may contain
eggs or dairy) and vegan (a vegetarian diet devoid of all animal products) describe plant-based diets of considerable
variability. Note that in this thesis the term vegetarian is often used instead of ‘vegetarian and vegan’.
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•

Contrary to popular perception, satisfaction with vegetarian diets in a clinical setting is as
high if not higher than non-vegetarian diets.150 This may be true in a non-clinical setting as
well, for example one study of young adults suggested that for some a vegetarian dietary
pattern may be easier to adhere to than other weight-loss diets.151 Of course, this may reflect
satisfaction with the dietary pattern for reasons pertaining to personal preferences (e.g. taste)
and/or effect (e.g. weight loss, perception of health) and/or the strength of motivators that
lead to adopting a vegetarian diet.

Regardless, it clear that long-term adherence to a

vegetarian dietary pattern in both free-living and structured settings is possible; however, for
patients enrolled in clinical lifestyle modification programs structured support is likely
needed for maximal adherence.152

Motivation for dietary adherence in vegetarians: a wide range of potential motivators
The literature demonstrates that a wide range of motivators influence the choice and maintenance
of a vegetarian diet and that many, if not most, ‘strict vegetarians’ are motivated by more than
one factor.153-156 These motivators are not limited to a concern for health or body-image but also
include ethical and environmental concerns surrounding intensive-confinement animal
agriculture, other socioeconomic and political issues, taste and spiritual or religious beliefs.
Given the highly personal nature of these motivators, it is not known whether the
motivational factors that influence self-initiated, vegetarian dietary patterns (other than
concern for health) can be employed in a clinical setting to facilitate long-lived, plant-based
dietary patterns and their benefits in non-vegetarians. The rational for employing these other
motivators stems from the observation that ethical & environmental concerns (referred to here
collectively as ecological concerns) play a significant role in strict adherence to a
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vegetarian/vegan dietary pattern for many, if not most, vegetarians.157-159 The strength of the
various motivators has not been studied but seems to vary from one nation or population to
another. For example, concern for health is often cited as the prime motivator to maintain a
vegetarian diet in the US,159 but in certain populations, namely British and Australian
vegetarians155,

156, 160, 161

and in teens,162-164 ecological concern is likely the prime motivator.

Nonetheless, the observation that health and ecological nutrition goals are remarkably
confluent151,

155, 156

suggests the potential utility of merging these motivators to induce

salutary dietary change and, in turn, weight loss or maintenance of weight loss in nonvegetarians – a hypothesis that is largely unexplored.

Dietary Adherence: a biological, theoretical and historical perspective
Joanna Dwyer, Ph. D. observed that throughout history the basis for restricting food intake in an
environment of abundant food is primarily philosophical.165 Whether the philosophy is based on
morals, values, spirituality, religion, superstition, or beliefs about health and disease differs by
population and time period. Still, a common element of all groups that are successful at longterm dietary adherence is the possession of a philosophy or culture that leads to dietary
restriction despite the presence of abundant food. This is certainly true for self-selected
vegetarians in Western civilizations.
To suggest that philosophy and culture (beliefs, attitudes, etc.) impacts dietary behavior is not to
say that biological mechanisms do not contribute to varying abilities to adhere to a relatively
restrictive dietary pattern. For example, the difficulty some people experience in avoiding high
fat or sugar-rich foods may be related to an opiod-like effect of fat and sugar molecules on the
brain, which induces neurobiological changes that eventually lead to behaviors designed to
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acquire more fat or sugar.166 In a related yet polar example, it is felt that once Anorexia Nervosa
begins physiologic disturbances may result that serve to perpetuate the illness.167 Thus it is likely
that philosophical, cultural and biological mechanisms contribute to the behavior of food
restriction.
On the other hand, there are strong biological and teleological explanations for over-eating in the
presence of food abundance.

As mentioned above, it is thought that we evolved through

significant periods of food scarcity. This situation selected for genetically-based (and perhaps
culturally-based) mechanisms that led to increased food intake in the presence of abundance and
an efficient ability to store food-energy as adipose tissue. An example of such a phenomenon is
sensory specific satietyvii, which accounts for why we eat more at buffets or multi-course meals
and why no matter how much is eaten there is always room for dessert!168 Although this is an
overly simplistic overview of the biological basis of eating behavior, it is fair to state that there is
sufficient evidence that a species-wide predilection for over-eating and fat storage exists that can
explain in part the cause of the current obesity epidemic: This predilection in concert with
increasing abundance of readily accessible high-calorie foods (caused by several factors)
and decreasing energy expenditure (due to technological advances, for example) is a certain
recipe for population-wide weight gain.
Thus, from a dietary perspective there are 3 major strategies that can be employed to decrease
food consumption in the presence of growing food abundance: 1) Decrease the food abundance

vii

Sensory Specific Satiety, more specifically, is a phenomenon regulated by the hypothalamus which encourages
maximal food intake. It appears as though the hypothalamus has different receptor thresholds for satiety for specific
flavors or attributes of food. If a meal contains both salty and bitter items for example, enhanced satiety occurs when
the receptor thresholds are met for both salty and bitter. (Thus salty and bitter items must be eaten in sufficient
quantity to reach satiety)The threshold for sweet is the highest of all thresholds, explaining why there is always
room for a sweet dessert after dinner and why virtually every culture has dessert at the end of a meal.
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(through government regulation, taxation, incentives, etc.); 2) Facilitate food restriction via a
variety of educational and behavioral approaches; and 3) Facilitate food restriction via surgical,
pharmacological or genetic means. Given the extent of the current obesity epidemic there is
sufficient rational for applying all available means of treatment and prevention. This thesis
discusses an educational and behavioral approach that aims to impart both a scientific and
philosophical approach to healthy, long-term food restriction (i.e. dietary adherence) for
improved weight management.

Dietary Behavior Change: theory and application
The theoretically-based field of dietary behavior change is still in its infancy. It is a recent
outgrowth of the broader field of behavior change which was developed largely by psychologists
to aid attempts at inducing smoking cessation. It is not known to what degree concepts or
principles of behavior modification for smoking cessation, for example, can be applied to dietary
change. However, well-established principles of behavior change likely bear some relevance for
efforts aimed at dietary behavior change. This review will not serve as a comprehensive review
of behavior change or dietary behavior change theory. Rather, the text that follows provides a
brief overview of concepts that influenced the design and rational for the intervention being
studies.
The theoretical model that most heavily influenced the design of the study intervention is the
Pressure Systems Model (PSM) of Behavior Change. The PSM was developed by David Katz in
an attempt to combine the most efficacious components of current behavioral change models into
a single, clinically oriented model.169 The PSM asserts that change occurs when net motivation
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exceeds net resistance. Using this simple model, the PSM attempts to guide clinicians to provide
stage-appropriate, efficient and effective counseling. For example, if a patient’s resistance to
change a particular behavior is exceeding high, efforts to enhance motivation to change will
likely be futile. Instead, efforts aimed at reducing resistance would be more appropriate. In
theory, one can also apply this model to group interventions by using a balance of strategies
aimed at raising motivation and lowering resistance to change.
From a motivational standpoint, the study intervention (called “the vegan healthy eating
program”) can be described as a meaning-based approach to achieving dietary change and
weight loss. This terminology is borrowed from a branch of psychology developed by Victor
Frankl termed logotherapy.170 The basic premise of logotherapy is that helping a patient find
meaning or purpose in a difficult situation can aid the patient’s ability to deal with that situation.
Within reason, it can be theorized that any struggle can be endured if it is deemed meaningful
enough by the person undergoing it. This concept can be applied in one of two ways to dietary
behavior change. First, because some psychologists argue that dysfunctional eating habits stem
from more general psychological/psychiatric processes (e.g. lack of self-esteem, meaning, etc.),
logotherapy can be used to target those dysfunctional processes and thus indirectly change eating
habits.171 Alternatively, as is the case with the study intervention, our goal was to help patients
discover a meaning that can help them endure the struggle of changing eating patterns. As
discussed above, our intervention was based on applying the motivations that allow vegans and
vegetarians to maintain strict, long-term adherence. Another way to view these motivators is as
cognitive processes that impart a meaning that outweighs the challenge of changing eating
patterns; or in the terms of the PSM, a motivation that outweighs the resistance. It is important
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to note, however, that this study was not designed to test these theories and hypotheses. If
anything, this study will help further develop hypotheses best tested by other methods.
The behavioral constructs and goals underlying the content of the study intervention were
intended to be consistent with the Pressure System’s Model as well as the key components of the
leading theoretical models, including the Transtheoretical Model (i.e. the stages & processes of
change),172 Social Cognitive or Social Learning Theory (i.e. self-efficacy, locus of control),173-175
the Theory of Reasoned Action (i.e. belief sets shape attitudes, intentions and behaviors)176 and
the Health Beliefs Model.177 For instance, participants were selected based on their stage of
plant-based dietary change (i.e. those in an active phase were excluded) to ensure that the
informative / educational nature of the intervention was stage appropriate. One of the
intervention goals was to advance participants’ stage of plant-based dietary change. Thus the
intervention was geared towards a pre-contemplative or contemplative stage. The breadth of the
topics covered and their mode of delivery was intended to influence several beliefs and attitudes
about food choices, while internalizing health, nutrition and social loci of control. An attempt
was also made to address several barriers to behavioral change including poor self-efficacy,
attitudinal ambivalence, and optimistic bias.viii However, given the novelty of this intervention,
future research will be needed to determine optimal formats for delivery of this type of
educational intervention, with respect to both specific patient populations and group vs.
individualized settings.

viii

Self-efficacy is defined as the belief that one can accomplish a specific task. High self-efficacy is thus task
specific and has been consistently linked to improved health-related outcomes.178 Attitudinal ambivalence refers to
the fact that individuals “do not always have clear-cut attitudes, but rather can be ambivalent about foods and about
healthy eating, and this factor might impact on the translation of beliefs and attitudes into behavior.” Optimistic bias
refers to the observation that most people tend to significantly underestimate their risk of injury or disease.178 Low
ambivalence is likely needed to allow new attitudes and beliefs to translate into dietary behaviors.180
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Preliminary Studies
Barnard et al have completed a weight loss intervention (publication pending) comparing a lowfat vegan diet to an American Heart Association’s Step 2 diet. Participants included 64
overweight and obese post-menopausal women with an average BMI of 33, recruited via
newspaper ads in Washington, D.C. The intervention consisted of 14 weekly, one hour group
meetings which provided detailed nutrition information and cooking instructions to participants
and their spouses/family members. Energy-intake limits were not prescribed and participants
were asked not to change current exercise habits. At 14 weeks, mean intervention group body
weight had dropped 5.8 ± 3.2 kg, compared to 3.8 ± 2.8 kg in the control group (P < 0.05).
Changes in intervention group body fat percentage were negatively correlated with fat intake (r =
- 0.40, P < 0.05) and energy intake (r = - 0.38, P < 0.05). Longer term follow-up is still underway
to assess the sustainability of dietary changes and weight loss in this population.
While Barnard et al’s study tests the efficacy of a vegan diet (independently) to affect weight
loss, it differs from ours in 3 important ways: their intervention did not include an ecological
nutrition component, included only women and may have included a healthier population that is
not fully representative of a university weight management clinic population (i.e. both
overweight and obese individuals, likely with less co-morbidities compared with our target
population).
While researchers continue to examine the health impacts of plant-based dietary patterns and the
mechanisms that underlie food choices, a review of the literature and contact with experts in the
fields of vegan nutrition, obesity and dietary change do not reveal ongoing intervention studies
addressing the potential clinical application of ecological nutrition education.
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SUMMARY OF BACKGROUND & SIGNIFICANCE:
The benefits of plant-based dietary patterns on weight and other health parameters
are becoming increasingly well understood. However, little is known about how to
facilitate

long-lived

plant-based

dietary

patterns

in

obese

individuals.

Furthermore, it is not known whether patients seen at university-clinics can be
motivated to adopt strict plant-based diets for the purpose of weight control and
health promotion. If a diverse set of motivational factors that influence selfinitiated, vegetarian dietary patterns can be employed to facilitate dietary change
in non-vegetarians in a clinical setting, this approach may have both important
clinical and public health implications. A pilot study as outlined in this thesis
would provide preliminary evidence that might warrant longer-term investigation
of this approach.

Regardless of the efficacy of the intervention, this study will also help identify the
feasibility of and barriers to recruiting patients to participate in a behavioral
intervention that employs other motivators in addition to personal health and wellbeing in a manner consistent with current dietary behavior change theories.

24

PURPOSE
The purpose of this study was to pilot a novel approach to facilitating dietary change in obese
adults, with the hope that this approach may eventually aid attempts to achieve longer-lived
changes compared to currently available treatments.

Primary Aim:
To determine whether exposure to vegan environmental, health and ethical issues can influence a
short-term change in dietary pattern in obese adults, when delivered in the context of personal
health promotion, through a group-based, educational nutrition program (referred to as a vegan
healthy eating program).

Secondary Aims:
1. To determine whether participation in an vegan healthy eating program can facilitate weight
loss, a change in blood pressure, glycemic control or lipids, or help maintain recent weight loss
in obese adults.
2. To provide pilot data for a future, more extensive RCT, including the ability to recruit and
general acceptability of this approach to dietary education.
3. To begin validation of an intervention specific behavioral questionnaire, which will assess
psychosocial variables, as well as diet and lifestyle behaviors.
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Hypothesis:
It is hypothesized that participation in a vegan healthy eating program will facilitate a shift
towards a plant-based dietary pattern and will contribute to weight loss or the maintenance of
weight loss in obese adults. The weight loss achieved from this approach is hypothesized to
confer the same medical and psychological benefits that are widely described in the literature and
are outlined in the Background section.

Hypothesis testing:
While this study was designed to have sufficient power to detect a change in several important
indicators of dietary pattern, it is likely to be underpowered to detect changes in the other
measures. (please see methods section below for further details) The data on these measures will
serve as valuable pilot data for designing future longer term, controlled trials to asses the efficacy
of a vegan healthy eating program in long-term weight management and comprehensive lifestyle
modification programs.
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METHODS
General Study & Intervention Design
This study was initially designed as a partially randomized and controlled, prospective pilot
intervention trial with a total of 3 months of follow-up. However, preliminary analyses suggested
positive outcomes and participants were invited to continue in the study for an additional 6
months.
The identical intervention (described below) was given sequentially to 2 groups of participants
(Group 1 N=14, Group 2 N=15). Prior to enrolling it was disclosed that one group one convene
on a Monday night the other on a Wednesday night. Participants who were able to attend either
group were randomized to one group or the other. Participants who were enrolled in the second
group 4 or more weeks prior to its commencement were asked for two sets of baseline data (once
upon enrolling, once just prior to commencing the intervention), thus providing some
“controlled” data. This “control period” was designed to measure the short-term effect of
enrolling in the study, without any other intervention.
Data (behavioral and food-frequency questionnaires, BMI, blood pressure, Duel-Energy X-Ray
Absorptiometry (DEXA) scan, 4-day Activity Monitor, and serum samples to examine lipid
levels and HA1c) were collected from all participants at baseline, and following the intervention
period at approximately 3 months after baseline, and again at 9 months after baseline for those
who continued the study. In addition, the behavioral and food frequency questionnaires, and
body measurements were repeated at the end of the control period and after the intervention was
completed (approximately 2 months post baseline).
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The intervention was a 6 week vegan healthy eating program modeled after Barnard et al’s
intervention. However, this program contained less intensive health and nutrition education and
incorporated in depth discussions on the ethical and environmental impacts of personal food
choices. The program consisted of 6 weekly, two and a half to three hour sessions and
approximately half an hour of suggested “homework” between sessions. Each session included
1-2 hours of presentation (a documentary video, guest lecture, etc.) and 0.5 - 1 hour of facilitated
discussion.
Bi-weekly, one and a half to two hour, maintenance sessions beginning after the core sessions
were offered to patients for 6 weeks (i.e. 3 sessions). An additional session was offered in the
middle of the remaining 6 months of follow-up. These sessions were tailored to the requests or
needs of each group.
The program was presented as a tool to gear participants to adopt a low to moderate fat, wholefoods, plant-based diet. The health, environmental and ethical arguments for moving towards this
dietary pattern were presented and discussed during the program. Practical tips (such as recipes
and shopping tips) were also made available for participants and were explored in greater depth
during the maintenance sessions. Materials that were suitable for the program, but could not be
utilized given time constraints, were available for independent study (i.e. homework), which
afforded the ability to further tailor information to individual needs and reinforced material
covered in the program. The topics of the core sessions are as follows:
Session 1. Introduction: overview of study, sessions, obesity and basic vegan nutrition.
Session 2. Your health: the health benefits of a low-fat, whole foods, vegan diet.
Session 3. Your health and more: an overview of the environmental, ethical and health effects of
diet.
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Session 4. Ecology: the environmental impact of animal-based agriculture. And: Optimizing
vegan nutrition: fruits, vegetables, whole grains and important supplements.
Session 5. Where your food comes from: animal biology, intensive confinement practices, factory
farms and the treatment of food-animals.
Session 6. Fast food and food safety: health and social rationale for avoiding fast food restaurants.

A more detailed curriculum is provided as the appendix section.

Subject Selection
Who and Why
Obese adults, aged 21 or above, and in stable medical condition, were recruited by primary care
providers at the UCSF Weight Management Program, the UCSF Diabetes Clinic or the UCSF
Gastroenterology Clinic. Recruitment methods are described below. This generated a
convenience sample intended to be somewhat representative of patients seen at a universitybased weight management clinic. A portion of the sample (n=6) had already lost 5% or more of
their body weight in the prior year, affording the opportunity to study qualitatively the
experience of those seeking to maintain weight loss. The inclusion of three referral clinics was
for the sake of feasibility. No special populations, such as minors or AIDS patients, were
recruited. The baseline characteristics of the participants are presented in the results section.

Sample Size
This pilot trial aimed for a sample size to assess short-term, within group change in selected,
clinically relevant variables of dietary pattern (intake of total calories, fat, saturated fat, total
fiber, cholesterol, fruit and vegetable servings) with sufficient accuracy. Based on results from
Barnard et al’s trial,179 we calculated that a sample size of 25 was required to achieve the
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accuracy levels given in the table below, using a 95% confidence interval. This N was multiplied
by 1.2 to allow for anticipated attrition to give a recruitment goal of 30 participants. These 30
participants would attend either a Monday intervention group or a Wednesday intervention group
(i.e. 15 participants per group) as discussed above in the general study design section.
In addition, sample size was calculated using a measure of dietary quality, the Recommended
Food Score (RFS). The RFS was developed by Kant et al as 23 item index based on weekly
consumption of selected food frequency items using the Block Food Frequency Questionnaire. In
a study of a cohort of 42,254 women in the Breast Cancer Detection and Demonstration Project
(BCDDP), a 4th quartile score corresponded to a 30% reduction in mortality compared to those in
the 1st quartile. In this cohort, the mean RFS was 11.2, and the within group SD was 4.1.180 A
sample size was calculated to detect a mean increase of 3 points (which corresponds to an
approximate increase of one quartile in the BCDDP cohort), assuming a within person
correlation of measurements near 0.85 and a ratio of control to experimental patients near or just
below 0.5. Using the same attrition factor of 1.2 a sample size of 28 was found. Thus, our sample
size goal was refined to a minimum of 28 and (desired) maximum of 30 participants.

Figure 1. Sample Size Calculation 1
95% CI

Sample size

Mean

SD

Acceptable
Variation

Drop in Total Kcal

365

612

500

115

615

25

30

Drop in Total Fat

44

33

33

27.5

60.5

17

20.4

Drop in Saturated Fat

18

15

20

8

28

10

12

Drop in Cholesterol

213

129

150

138

288

13

15.6

Increase in Total Fiber

9

11

10

4

14

20

24

Increase in Fruit Servings

1

2

1.8

0.1

1.9

20

24

Increase in Vegetable Servings

1

2

1.8

0.1

1.9

20

24

Variable

Lower

Upper

Raw

Total*

*Note: Attrition Factor of 1.2 used to calculate Total N from Raw value.
Source: Barnard Data set (change from baseline to 14 weeks); Vegan Group data only
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Figure 2. Sample Size Calculation 2
Reported between person SD

4.1

Correlation of measurements within a person

0.85

Calculated within person SD

4.10

ratio of control to experimental participants

0.5

N of experimental group

15

N of control group

8

Total N*

23

N x Attrition Factor (1.2)

28

*To detect an effect size of 3 points, with an alpha of 0.05 and power of 0.8,
using an independent t test on the change scores.

Inclusion/Exclusion Criteria
The suitability of each patient, according to the inclusion/exclusion criteria (listed in Figure 3 on
the following page), was evaluated by medical history, an oral questionnaire, the ability to read
and comprehend the consent form, vital signs, and when necessary, contact with a primary care
physician, psychiatrist or medical chart review.
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Figure 3. Inclusion an Exclusion Criteria
Inclusion Criteria

Exclusion Criteria

Participants must be:

Potential participants will be excluded if:

At least 21 years of age,

They have conditions that might interfere with participation
or follow-up. These include:

male or female,

alcohol or drug addiction,

of any ethnic group.

severe depression or anxiety,
In stable medical condition.

an inability or unwillingness to attend all
sessions,

At a BMI greater or equal to 30.

a language barrier,

Able to independently perform Activities of Daily
Living, including the ability to shop for/prepare
meals, and travel to the intervention sessions.

an inability to read at a grade 8 level,
an uncorrected visual/auditory impairment,
a serious personality disorder (e.g. antisocial,
borderline, narcissistic).
They have a condition that might interfere or alter weight
loss. These include:

•

being vegetarian (lacto-ovo or vegan) at the
time of enrollment,

•

the use of pharmacotherapy for weight loss,

•

concurrent use of Very Low Calorie Diet
therapy,

•

prior bariatric surgery,

•

malignancy,

•

pregnancy.

Subject Recruitment
Sources
Potential subjects were identified from a database of patients seen at the UCSF Gastroenterology
Clinic in the 36 months prior to the recruitment period (n=142 patients), as well as from new or
current patients seen by 9 (nine) providers at the UCSF Gastroenterology Clinic, UCSF Diabetes
Clinic, and UCSF Weight Management Program during the recruitment period which lasted 2
months, 9 days. (Please see recruitment flow diagram in the results section) The study
intervention was presented as a complimentary or alternative treatment for either a) aiding
dietary improvement, b) the maintenance of weight loss and/or c) weight loss as appropriate.
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Enrollment occurred on a first come, first serve basis and recruitment was stopped once the
recruitment goal was met.

Initial Contact Methods and Screening
A letter from their care provider at the clinic and a pamphlet that describes the study and the
inclusion and exclusion criteria was mailed (in the case of database patients) or given by the care
provider (in the case of new or current patients) to all prospective participants along with an
invitation to contact a member of the research team by phone for more information or to learn
how to enroll in the study. Initial screening took place over the phone after which potentially
eligible patients were asked to come to the UCSF General Clinical Research Center for final
screening.
A copy of the recruitment pamphlet can be found in the appendix section.

Consent Process and Documentation
The study aims, design, risks and requirements were explained to all potential participants by the
study PI. An outline of the sessions’ contents (similar to that provided in the appendix) was also
given to potential participants to read, after which questions were encouraged. All subjects were
asked for a medical history and vital signs to ensure that they were in stable health condition.
Once subjects were deemed to be eligible for and interested in the study, they were given a fullyinformed written consent form to read and sign. For those who refused participation in the study,
reasons for refusal (if given) were documented. All records and questionnaires were kept
confidential according to standard medical practice. At the end of the 3 month pilot, all study
participants were invited to continue in the study and, if interested, were asked to read an
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additional fully-informed written consent form outlining the procedures, potential risks and
benefits of continuing the study for an additional 6 months. Those who did not wish to continue
participation in the study were asked if they were willing to explain why. They were told
verbally that they remained free to end their participation without explanation.

A copy of the consent form can be found in the appendix section.

Study Procedures
Study Site
All study procedures were conducted at the General Clinical Research Center (GCRC) at the
University of California, San Francisco (UCSF), 505 Parnassus Avenue, Room M-1296, San
Francisco, California 94143.

Group Allocation and Randomization
Participants were informed that there will be 2 identical groups, one that takes place on
Mondays, one on Wednesdays, and that one of these will start before the other. Participants that
could only attend the Monday or only the Wednesday group were assigned to that group.
Participants that could attend either group were randomized (using a 2:1, Monday: Wednesday
ratio) to one of the groups. Participants who enrolled in the Wednesday group 4 weeks prior to
its commencement were asked to contribute 2 sets of baseline data – one upon enrolling, the
other right before their group commenced - so as to contribute “control period” data.
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Figure 4. Randomization & Group Allocation

Data Collection and Outcome Measures:
A list of data sessions and outcome measures appears in Figure 5 on the following page. This is
followed by description of the standardized techniques used for collecting data and the statistical
methods used to generate outcome values (where appropriate). All data was collected by a
trained research nurse, the study PI or a co-investigator. Data was entered into a custom
designed Microsoft Access 2002 v 10.4 relational database by 2 trained research assistants.
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Figure 5. Schedule of Outcome Measures
Measure
Activity Monitor (4 day)

Baseline 1*

Baseline 2*

Intervention

Month 2

X

Attendance

Month 3

Month 9

X

X
X

X

Behavioral Questionnaire

X

X

X

X

Block FFQ

X

X

X

X

X

Blood Pressure

X

X

X

X

X

X

X

X

X

X

X

X

X

Blood Draw (Lipid profile, HA1c)

X

Body Measurements (Weight, height)

X

Demographic Questionnaire

X

DEXA Scan

X

Exercise Questionnaire (YPAS)

X

Satisfaction & Acceptability Questionnaires

X

X

X

X

X

Abbreviations: FFQ, Food Frequency Questionnaire; HA1c, Glycosylated Hemoglobin; DEXA, Duel-Energy X-Ray Absorptiometry; YPAS,
modified Yale Physical Activity Survey
*Baseline 1 refers to data collected upon enrolling in the study. Baseline 2 refers to data collected at the end of the control period.

Figure 6. Standardized Measurement Techniques & Statistical Methods
Blood Pressure:
Participants were asked to sit relaxed, for 5 minutes. The appropriate size cuff was placed on their left arm, directly
over skin, with the arm resting so that the cuff was at heart level. Both the systolic and diastolic blood pressures were
measured with an electronic cuff (Dynamap™), with 2 minute intervals between each measurement. 3-4
measurements were recorded depending on time availability in the research ward.
Average systolic and diastolic blood pressures were calculated as follows. The first measurement was discarded, then
the remaining 2 or 3 measurements were averaged.
Weight:
The same digital scale (capable of weighing up to 350 Kg) was used for each measurement. The scale was zeroed
prior to each measurement. Participants were encouraged to void their bladder prior to the measurement. Participant
were asked to be bare foot (or wearing socks, but NO shoes), and to wear a hospital gown or street clothes, but NO
jacket, sweater, belt, heavy jewelry or items in pockets. The weight was recorded in Kg to 2 decimal places.
Height:
The same wall mounted Harpenden stadiometer (Holtain, Dyfed, UK) was used for each measurement. Participants
were asked to be barefoot or wearing socks (but NO shoes). Participants were instructed to stand with their heels
together, buttocks and back pressed against the stadiometer. Then they were asked to “look forward and stand tall”
while keeping their feet flat on the ground and weight distributed evenly on both feet. Participants were then asked to
take a deep breath in, then exhale. During the exhalation the moveable headboard was brought down until it touched
the superior-most part of the head, such that their hair was compressed. Height was then recorded in cm to 1 decimal
place.
DEXA Scan:
All DEXA body composition measurements were performed using the same LUNAR Prodigy DEXA scanner
(Madison, WI), which expressed body composition as total fat mass (g), total lean mass (g), and total body mass (g).
Scans were obtained at baseline, 3mo, and 9mo visits. Scanning was performed using a standard protocol with "thick"
mode scanning. All scans were performed by the same trained research nurse.
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Figure 6 Continued. Standardized Measurement Techniques & Statistical Methods
Activity Monitor (AM):
Physical activity was assessed using RT3 tri-axial research tracker accelerometers (Stayhealthy Inc., Monrovia, CA) at
baseline, 3 month, and 9 months after baseline. Participants were given the activity monitors for a minimum of four
days, with instructions to wear the monitor at all times except during sleeping and bathing. Participant were instructed
to position the AM on their right hip near the Anterior Superior Iliac Spine (ASIS).
After return, data was downloaded from the activity monitor, including Vector Movement, Activity Calories (kcal),
and Total Calories (kcal). Based on age, weight, and height, the software calculated Basal Metabolic Rate, Activity
Calories, and Total Calories using the following equations:
Basal Metabolic Rate (male): ((473*weight)+(971*height)-(513*age)+4687)/100000
Basal Metabolic Rate (female): ((331*weight)+(352*height)-(353*age)+49854)/100000
Activity Calories: ((average Vector Movement/10)*(weight*1.692))/10000
Total Calories: Activity Calories + Basal Metabolic Rate
A maximum of four and a minimum of two valid measurement days were used for analysis. A valid measurement day
was defined as having at least eight hours of non-zero Vector Movement from 8am to 8pm, and at least two hours of
non-zero Vector Movement from 8pm to 8am. Average Vector Movement, Activity and Total Calories per day were
calculated from a multiple of 24 hours (48, 72, or 96 hours). Subjects with less than two valid measurement days
during one session had a second measurement session of four or more days.
In total, five activity monitors were used for all participants. Intra- and inter-monitor reproducibility was assessed on
two separate occasions, in which the monitors were placed on a shaker box for a 48 hour period, with the first 24
hours in a prone position and the second 24 hours in an upright position orthogonal to the prone position. For each of
the two 24 hour segments, inter-monitor precision was calculated as the average and standard error (SE) of total
Vector Movement for each of the five monitors, with precision calculated as the ratio of SE/average (percentage).
Intra-monitor reliability was assessed by comparing each of the 24 hour segments in two separate shaker box sessions.
For each of the two 24 hour segments, the difference in total Vector Movement was measured and percentage change
was calculated as the difference/average (percentage).
To minimize variability, participants were given the same AM at each measurement whenever possible. Although it
was intended that each participant would only use one AM, this was not possible as one AM was lost and 2 broke
during the testing period and had to be repaired. In addition, the average Vector Movement per day was used as the
primary measure to assess change in activity as this measurement has the least variability associated with it.
Labs:
The day prior to their data session appointment, participants were reminded to be fasting from midnight onwards (or
for at least 8 hours prior to their appointment). They were encouraged to drink water but asked not to take other fluids
or food during the fasting period. They were reminded to take their medications as per usual. All blood draws were
performed by a trained research nurse at the GCRC. In the rare case that a blood draw could not be obtained by the
research nurses (i.e. for technical reasons), participants were given a requisition slip and note to allow the blood to be
drawn at a local Unilab™ office. Two 10 ml SST tubes were drawn for a lipid panel and fasting glucose, and one 3 ml
purple-top tube was drawn for a HA1c measurement. All tubes were labeled and sent to Unilab™ for analysis.
Participants were free to refuse a blood draw on any visit.
Surveys:
Standardized instructions for all surveys were contained within each survey. Prior to each survey administration,
participants were given a verbal summary of the instructions and asked to read all instructions carefully, to take their
time answering questions and to ask for clarification at any time. They were free to refuse to answer any questions. A
description of each survey used is found below. A copy of the surveys can be found in the appendix section. All
survey instruments were reviewed by both the UCSF Committee on Human Research and the UCSF GCRC Advisory
Committee.
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Figure 6 Continued. Standardized Measurement Techniques & Statistical Methods
The Block 98.2 Food Frequency Questionnaire (FFQ):
This FFQ was validated by Block et al after updating their original FFQ to reflect data from the National Health and
Nutrition Examination Survey III (NHANES III).181 The Block 98.2 FFQ was chosen from available validated FFQs
because it contained food items relevant to the study intervention (e.g. soy milk, tofu, meat alternatives) and allowed
for separation (during analysis) of the majority of items into plant or animal-origin (see below). In addition, the Block
food diagram (a pictorial representation of serving sizes using wooden blocks on plates and bowls) was felt to
contribute an advantage over other FFQs because of the likely variability in perceptions of ‘servings’ that may exist in
this study population. A 3-7 day food diary would have offered more accurate nutritional data, but this method was
not chosen for this pilot study for feasibility concerns. The Block FFQ was used as is, with the exception of the time
frame for questions, which was manually changed from “past year” to “past month” on each survey. The ‘Block food
diagram’ was explained prior to starting and was used every time the survey was filled out. The completed FFQs were
checked for completeness and participants were asked complete any missing items.
Berkeley Nutritional Services (Berkeley, CA) performed all of the raw FFQ analysis by scanning each survey using an
Optical Mark Reader and then comparing the item results with a standardized nutrient database. This analysis returned
values for each item assessed as well as summary variables for standard macro and micronutrients as well as estimated
servings of fruits, vegetables, meats, etc. Average macronutrients, micronutrients, and food servings served as the
primary values for assessing change in diet. The raw values for each item assessed were used to calculate a
Recommended Food Score (RFS), a measure of overall dietary quality.
In addition to the above analysis, the Block FFQ was coded into plant, animal or other items. Other items included
items that described foods that could contain either animal or plant foods (e.g. Chinese food, pizza, etc.) and also
included plant-based items with well established deleterious effects (e.g. French fries, candy). Coding decisions were
made prior to patient enrollment by the study PI and were reviewed by the research dietitian at the Preventive
Medicine Research Institute. The objective of coding the FFQ into plant, animal or other was to allow for the
generation of 2 novel dietary indexes that may be able to assess a “shift to a plant based diet”. One index (the PDI)
excluded the ‘other’ items as a means of comparing plant to animal items. The other index (the PDIT) included all
food items as a means of assessing the proportion of plant calories in the diet. The indexes were calculated as follows:
Plant-based Diet Index (PDI) =
(total plant calories/ total plant calories + total animal calories) x100
Total Plant-based Diet Index (PDIT) =
(total plant calories/ total plant calories + total animal calories + total other calories) x100
A list of the Block FFQ item codes can be found in the appendix section
Behavioral & Demographic Survey:
This survey instrument was designed for this study in an attempt to measure perceived dietary change, behavior
change (e.g. stage of change, self-efficacy, intention to change, etc.), as well as relevant attitudes, beliefs, and
knowledge. Whenever possible previously validated questions and scales were utilized. For example, the VeganOmnivore Scale was included in this survey as a validated measure of perceived dietary change, which has correlated
well with 3-day food recall.153 Where it was not possible to find previously validated questions and scales, questions
were modeled after similar questions reported in the literature. Once a draft of the survey was complete it was
reviewed by several experts in vegetarian nutrition or dietary behavior change to asses face validity. Suggestions were
integrated into the survey and sent back to all reviewers for further comments.
A copy of the VHEP Behavioral and Demographic Survey can be found in the appendix section.
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Satisfaction Surveys: Anonymous satisfaction surveys were administered to each participant after every intervention
session with goal of measuring satisfaction with learning experience as well as the perceived value and acceptability
of the session. Before beginning each survey, participants were reminded that the survey is anonymous and were
encouraged to write comments (both positive and negative). They were then instructed to place the survey in a
collection box prior to leaving. In the case of a make-up session, participants were not asked to fill out a satisfaction
survey as anonymity would not be possible. An additional post-course satisfaction survey was administered to assess
the relative perceived value, acceptability and satisfaction of each of the program’s components in hindsight. This
survey was not anonymous in that it required the participants to place their assigned StudyID on the front page. All
surveys were reviewed prior to administration by an experienced biostatistician.

Statistical Methods:
Data was collected and stored as described above. After the data was cleaned, it was exported to
SPSS v11.5 for Windows for statistical analysis. A hierarchical analysis was performed as
follows. Outcome measures collected at the start and the end of the control period allowed for a
comparison of changes in selected variables in the intervention group vs. the control group (i.e. a
between group analysis). Since the control period was relatively short and coincided with the
start of the intervention period for group 1 only, the between group analysis compared only
group 1 participants (n=13) to control participants (n=8). Of most importance is the between
group analysis comparing group 1 immediately after the intervention (approximately 7.3 weeks
after baseline) to the control group (of approximately 4.3 weeks duration). However, this same
analysis was repeated comparing intervention group 1 at both 3 months (n=13) and 9 months
(n=8) post baseline to the control group. Please see figure 7, found at the end of this section, for a
graphical representation of the analyses.
Although the study was designed for 3 months only, an intention to treat between group analysis
was also performed on the 9 month changes by carrying forward 3 month changes for
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participants who dropped out of group 1 after the 3 month period (n=5). For continuous
variables, between group differences were analyzed by 2-tailed, independent Student’s t-tests on
the change scores of the intervention vs. control group. Prior to running the t-tests, Levene’s test
for equality of variances was run to determine whether or not the Student’s t-test should assume
equal or unequal variances for each variable. For ordinal or categorical variables, a MannWhitney U test was substituted for the Student’s t test.
In addition to a between group analysis, within group changes were also assessed on all
participants (i.e. group 1 and 2) by 2-tailed, paired Student’s t-tests on the before and after scores
(for continuous variables) for each time period (i.e. control, and intervention at 2, 3 and 9
months). For ordinal or categorical variables, the Wilcoxon Signed Ranks test was substituted for
the Student’s t test. An intention to treat analysis was also performed on the 9 month scores by
carrying forward 3 month values for participants that dropped out after the 3 month point (n=5).
Correlations were calculated on the within group change scores for each time period. For
continuous variables, Pearson’s correlation coefficient was calculated. For ordinal or categorical
variables, Spearman’s correlation coefficient was calculated. When a correlation was assessed
between a continuous and an ordinal or categorical variable, the continuous variable was first
converted to an ordinal variable by assigning a quintile of change to each variable change score.
Then a Spearman’s correlation was computed comparing quintiles of change of the continuous
variable to either change or end scores of the ordinal or categorical variable.
Finally, logistic regression analysis was performed on within group weight and BMI change to
assess the contribution of potential confounders (e.g. activity change) and socio-demographic
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factors. This analysis was performed on Statistical Analysis System (SAS) for Windows version
8.2 (SAS Institute, Cary, NC).
Figure 7. Diagram Comparing Between vs. Within Group Analyses on Control and Intervention Groups
Start

------------------------------------ Time --------------------------------------- … … … …

Between
group
analysis

Group 2
Group 1
Control

2 Mo
End

2 Mo
3 Mo

3 Mo

9 Mo
9 Mo

End
Within
Intervention
Group
Analysis

Within Control
Group Analysis

Solid Boxes represent data collection timepoints (baseline collection not shown)
Group 1 (gold) +Group 2 (dk. blue) = Intervention Group

Intervention Period Procedures:
Each intervention session (i.e. a session of the vegan healthy eating program) was held on the
same day of the week (Monday for Group 1, and Wednesday for Group 2), beginning at 6 pm
and lasting until 8:30 or 9pm. An outline of the curriculum is found in the Appendix Section. All
sessions were facilitated by the study PI. Each session had a number of components including a
group check-in, one or two lectures, and one or two discussions or question and answer periods.
All components were led by the PI with the exception of the guest lecturers, as listed in the
curriculum. Whenever possible, make-up sessions or independent-study options were offered
during the intervention period to those that miss a session.

Post Intervention Procedures:
After the 6 week intervention, three additional “maintenance sessions” were offered every
second week. As discussed above, these lasted 1.5-2 hours, and focused on more practical
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matters, such as cooking techniques. After these 3 maintenance sessions the 3 month pilot trial
concluded and all participants were invited to continue in the study. Those who remained in the
study were offered continued, albeit lesser, support over the next 6 months of follow-up. During
this period, one more maintenance session was held, one group mailing was sent out (containing
a few relevant recent articles, and a letter of support) and individualized telephone counseling
was provided. Telephone counseling was performed by the PI for an average of 34 minutes per
phone call, 1.7 times or approximately 57 minutes per participant over this 6 month period. Our
goal was to hold 2-4 maintenance sessions, send out 2-4 group mailings, and offer phone
counseling for 10-15 minutes once per month. However, resource limitations prevented this level
of support from being offered.

Ethics board approval
This research was approved by and conducted under the standards held by the University of
California, San Francisco Committee on Human Research, as well as by the UCSF General
Clinical Research Center Advisory Committee.

Costs to the Subject
There were no financial costs to subjects that participated in this study.
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Reimbursement of Subjects
Participants were compensated $15 for each set of data analysis session they completed, with the
exception of the 9 month data session which was not compensated. Thus, a maximum of $60 was
given to each participant. Participants were reimbursed for either parking or public transport
expenses to attend each intervention session, maintenance session and data collection session.

Confidentiality of Records
Research records were not anonymous so as to allow for calculation and analysis of change
scores. However, all records were coded using a numeric subject ID code assigned when
participants enrolled. Data was entered with the subject ID instead of the participant’s name. A
master key was kept that matches ID’s with participants name until data entry and analysis was
complete. Consent forms were kept in a secure location within the General Clinical Research
Center, Moffitt Hospital.
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RESULTS
Recruitment, Retention, Attendance
A recruitment goal of 30 participants was set based on sample size calculations (described
above), allowing for 5 dropouts. However time constraints were considered when deciding to
close recruitment. At 2 months and 9 days, 29 participants had enrolled and recruitment was
closed. Using 3 UCSF ambulatory clinics, 279 patient contacts were made either indirectly by a
letter from their care provider (142) or by direct referral (137). Roughly 15.1% of patient
contacts contacted the study coordinator to be phone screened. Of these patients, 29 or 10.4% of
patient contacts enrolled in the study as they met all inclusion criteria and had no exclusion
criteria.
Figure 8. Recruitment Flow Diagram
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Of the 29 patients initially enrolled in the study, 4 dropped out by the end of the 3 month study
period. The reasons for dropout were: patient elected to have gastric-bypass surgery (n=1),
patient seeking rapid weight loss not compatible with the study intervention (n=1), reasons
unrelated to the study intervention (n=1), and reasons not given (n=1).
All patients enrolled with the intention of participating in the study for 3 months only. However,
an interim analysis suggested positive results warranting an extension of the study. At the end of
the 3 month period, all remaining participants (n=25) were asked to continue the study. Of these,
20 participants completed the extended study. Reasons for dropping out or not continuing the
study were: patient elected to go on very low calorie diet therapy (n=1), patient elected to go on
Atkins-type diet (n=1), reasons unrelated to the study (n=1), and reasons not given (n=2).

Baseline Characteristics
Table 1 on the following page summarizes selected socio-demographic characteristics of the
study participants. There were no significant differences in baseline characteristics among
intervention and control participants.

Time Changes
Average time between data timepoints was 4.3 weeks (SD=1.2) for the control group. For the
intervention group 1 average time from baseline was 7.5 weeks (SD=1.1) at the “2 month” point,
15.6 weeks (SD=1.7) at the “3 month” point, and 41.7 weeks (SD=7.0) at the “9 month” point.
For all intervention participants, average time from baseline was 7.3 weeks (SD=1.3) at “2
months”, 14.2 weeks (SD=2.1) at “3 months”, and 35.8 weeks (SD=7.2) at “9 months”.
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Table 1. Baseline Socio-demographic Characteristics
All Participants

Group 1

Control

(n=29)

(n=14)

(n=9)

F* or mean

% or (SD)

F or mean

% or (SD)

F or mean

% or (SD)

P Value†

Age

51.1

(10.0)

51.1

(10.7)

49.6

(11.5)

0.756

Baseline BMI

40.4

(8.4)

40.4

(8.7)

38.8

(10.4)

0.679

Baseline VOS

8.0

(1.9)

8.1

(2.0)

8.6

(1.9)

0.447

Baseline PDIT

34.4

(12.3)

32.8

(10.6)

33.5

(12.7)

0.374

African American or Black

7

24.1

2

14.3

4

44.4

White or Caucasian

22

75.9

12

85.7

5

55.6

Latino or Hispanic

3

10.3

0

0.0

1

11.1

Not Latino or Hispanic

26

89.7

14

100.0

8

88.9

Female

24

82.8

11

78.6

9

100.0

Male

5

17.2

3

21.4

0

0.0

some college

9

31.0

3

21.4

3

33.3

associate degree

1

3.4

1

7.1

0

0.0
11.1

Race

0.250

Ethnicity

0.688

Gender

0.403

Education Level

0.688

bachelor's degree

5

17.2

3

21.4

1

some grad school

3

10.3

3

21.4

0

0.0

master's/doctorate degree

11

37.9

4

28.6

5

55.6

single/living alone

16

55.2

9

64.3

5

55.6

married/living with partner

13

44.8

5

35.7

4

44.4

11

37.9

7

50.0

3

33.3

work less than 20 hrs/wk

3

10.3

0

0.0

1

11.1

work part time (20-39 hrs/wk)

1

3.4

0

0.0

1

11.1

work full time (40 + hrs/wk)

14

48.3

7

50.0

4

44.4

0 - $10,000

3

10.3

2

14.3

1

11.1

$11,000 - $20,000

3

10.3

1

7.1

1

11.1

$21,000 - $30,000

2

6.9

1

7.1

0

0.0

$31,000 - $50,000

3

10.3

1

7.1

2

22.2

$51,000 - $70,000

5

17.2

4

28.6

1

11.1

$71,000 -$90,000

4

13.8

1

7.1

3

33.3

$91,000 or more

7

24.1

2

14.3

1

11.1

28

96.6

14

100.0

8

88.9

Marital Status

0.734

Employment
not seeking employment

0.829

Combined Income

0.754

Medical Insurance
Yes

0.688

No
1
3.4
0
0.0
1
11.1
Abbreviations: F, frequency; BMI, Body Mass Index; VOS, Vegan-Omnivore Scale where 1=vegan and 10=omnivores; PDIT, Total Plant-based
Diet Index Score
†P values derived from 2-tailed, Mann-Whitney U test on categorical variables and 2-tailed, independent Student’s t-test on continuous variables,
comparing all participants to control participants.
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Change in Perceived Dietary Pattern
At each data session participants were asked to select a dietary category that most represented
their current diet. The figure below represents responses at each study timepoint. The proportion
of control participants who considered themselves vegetarian or vegan was 0% at baseline and
25% (all “dairy and fish vegetarian”) at the end of the control period (p for category change
=0.16). Among intervention participants, 10.3% considered themselves vegetarian or vegan at
baseline (all “dairy and fish vegetarian”) compared with 81% at 2 months (p=0.0001), 72% at 3
months (p=0.0001), and 70% at 9 months (p=0.002).

Percent of Intervention or
Control Group

Figure 9. Diet Category Frequencies at All Timepoints
100
90
80
70
60
50
40
30
20
10
0

Omnivore
Dairy & Fish
Vegetarian
Lacto-Ovo
Vegetarian
Vegan

Baseline

2 Mo

3 Mo

9 Mo

Control Control End
Start

Similarly, compared to changes observed during the control group there was a statistically
significant change towards a vegan dietary category in intervention group 1 at 2 months
(p=0.002), 3 months (p=0.016) and at 9 months (p=0.023).
In addition to selecting a dietary category reflecting their current diet, participants were asked to
rate their current diet on a Vegan-Omnivore Scale (VOS) - a scale from 1 to 10, with 1 labeled as
vegan, and 10 as omnivore. Figures 10 and 11 below represent responses in the control group,
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and responses in the intervention group, respectively. The baseline VOS for the control and
intervention participants was 8.6 (SD=1.9) and 7.7 (SD=2.3), respectively (p=0.96). The mean
change in VOS in the control period was -1.4 (SD=2.4, p=0.14). The mean change in VOS in the
intervention period was -5.4 (SD=2.4, p<0.001) at 2 months, -4.5 (SD=2.6, p<0.001) at 3
months, and -3.8 (SD=3.2, p<0.001) at 9 months. Mean changes are displayed in Figure 12.
Compared to changes observed in the control group there was statistically significant change
towards the vegan end of the scale in intervention group 1 at 2 months (p=0.004) and at 3 months
(p=0.021). However, this difference did not remain significant at 9 months (p=0.11).
Figure 10. VOS Responses for Control Participants
60.0

Percent of Contorl Group

50.0

40.0
Control Start
30.0

Control End

20.0

10.0

0.0
10 (Omnivore) &
9

8, 7, & 6

5, 4, & 3

2 & 1 (Vegan)

Figure 11. VOS Responses for Intervention Participants

Percent of Intervention Group
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Figure 12. Mean VOS Change in Control vs. All Participants
0.0

Mean Change in VOS

-1.0
-2.0
-3.0
-4.0
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2 Mo
3 Mo
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-5.0
-6.0

Changes in both reported diet category and Vegan-Omnivore Scale (VOS) correlated with
selected markers of dietary pattern as assessed by food frequency questionnaires. The correlation
matrix below (Table 2) presents within intervention group changes in diet category and VOS at
2, 3 and 9 months as correlated with quintiles of change of dietary variables and weight change.
In general, changes towards a self-reported vegan diet correlated with expected changes in
dietary components such as a reduction in saturated fat and dietary cholesterol and increases in
dietary fiber, fruits and vegetable servings, and plant-based diet indexes. A decrease in VOS (i.e.
a move towards vegan) correlated more consistently with a decrease in weight than did a change
in reported diet category.
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Table 2. Correlation Matrix for Changes in Dietary Components, Weight an Perceived Dietary Change
Intervention Group at
2 months

3 months

(n=25)
Quintiles of Change in
Kcal
Fat
Carbohydrates
Saturated Fat
Cholesterol
Fiber
% Fat
% Protein
% Carbohydrates
Fruits + Vegetable
Servings
Meat Servings
PDI
PDIT
Weight

Diet
Category
0.061

P Value
Correlation Coefficient

(n=25)
VOS

Diet
Category

0.193

-0.005

0.777

0.365

0.181

0.187

P Value

0.398

Correlation Coefficient

-0.085

P Value

0.691

Change in
Correlation Coefficient

9 months
(n=20)
VOS

Diet
Category

VOS

0.296

0.238

0.293

0.983

0.160

0.327

0.223

0.166

0.372

0.402

0.318

0.382

0.438

0.073

0.088

0.185

0.107

-0.075

0.045

-0.069

0.063

0.620

0.726

0.833

0.779

0.799

Correlation Coefficient

0.324

0.398

0.283

0.515

0.418

0.526

P Value

0.122

0.054

0.181

0.010

0.075

0.021

Correlation Coefficient

0.531

0.505

0.532

0.650

0.569

0.566

P Value

0.008

0.012

0.008

0.001

0.011

0.012

Correlation Coefficient

-0.539

-0.425

-0.491

-0.481

-0.649

-0.483

P Value

0.007

0.038

0.015

0.017

0.003

0.036

Correlation Coefficient

0.082

-0.002

0.059

0.345

0.563

0.279

P Value

0.702

0.991

0.784

0.099

0.012

0.247

Correlation Coefficient

0.082

0.141

0.067

0.178

-0.177

-0.040

P Value

0.704

0.510

0.755

0.406

0.468

0.871

Correlation Coefficient

-0.185

-0.124

-0.168

-0.405

-0.605

-0.418

P Value

0.388

0.562

0.433

0.050

0.006

0.075

Correlation Coefficient

-0.353

-0.012

-0.365

-0.394

-0.458

-0.494

P Value

0.090

0.956

0.080

0.057

0.048

0.032

Correlation Coefficient

0.097

-0.017

-0.103

0.183

0.047

0.192

P Value

0.654

0.939

0.633

0.392

0.850

0.430

Correlation Coefficient

-0.681

-0.675

-0.554

-0.665

-0.696

-0.726

P Value

0.000

0.000

0.005

0.000

0.001

0.000

Correlation Coefficient

-0.665

-0.564

-0.724

-0.719

-0.851

-0.750

P Value

0.000

0.004

0.000

0.000

0.000

0.000

0.248

0.399

0.174

0.279

0.450

0.740

Correlation Coefficient
P Value

0.233

0.406
0.177
0.048
0.047
0.000
Abbreviations: VOS, Vegan-Omnivore Scale; Kcal, Calories in Kcal; PDI, Plant-Based Diet Index; PDIT, Total Plant-Based Diet Index

Change in Plant-based Dietary Stage of Change
Stage of change in reference to adopting a plant-based diet (defined as “a diet that is mostly
made of grains, vegetables, fruit, beans and legumes, nuts and seeds, and includes very little or
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no foods made from animals, e.g. milk, meats, eggs, cheese, fish, etc.”) was assessed by a predetermined algorithm using two survey questions: 1) are you currently eating a plant-based diet?
and 2) if no, are you ready to start eating a plant-based diet now? A pre-contemplative stage was
defined by answering “No” to both questions. A contemplative or preparative stage was defined
by answering “No” to the first question and “Yes” to the second. An action stage was defined by
answering “Yes” to the first question. Participants were selected such that none were in the
action stage at baseline. At baseline, 75.9% of intervention participants were at a contemplative
or preparative stage and the remaining 24.1% were at a pre-contemplative stage. Among the
control participants at baseline, 88.9% were at a contemplative or preparative stage and the
remaining 11.1% at a pre-contemplative stage. These differences were not statistically significant
(p=0.31). At 2 months 92.3% of intervention participants reported being in an action stage (i.e.
currently eating a plant-based diet), 3.8% remained contemplative or preparative and 3.8%
remained pre-contemplative (p for within group change <0.0001). At 3 months 80% reported
being in the action stage, 16% contemplative or preparative, and 4% pre-contemplative
(p=0.0001). At 9 months 65% reported being in the action stage, 10 % in the preparative or
contemplative stage, and 25% in the pre-contemplative stage (p=0.012). In contrast, at the end of
the control period no participants reported being in the action stage, 37.5% remained in the
contemplative or preparative stage and 62.5% reported being in the pre-contemplative stage
(p=0.0455). The changes in reported dietary stage of change in intervention group 1 compared to
the control group were significant at 2 months (p<0.001), 3 months (p<0.001) and at 9 months
(p=0.045).
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Change in Dietary Components
Table 3 on the following page summarizes within group changes in selected dietary variables as
determined by food frequency questionnaire analysis. In general, small amounts of dietary
change were exhibited by the control group, reflecting a small shift towards a plant-based diet.
For example, the Total Plant-Based Diet Index (PDIT, which equals plant calories over total
calories x 100) increased by a mean of 6% (SD=5.4, p=0.026), dietary cholesterol decreased a
mean of 75.2 mg (SD=63.1, p=0.0198), and there was a slight but non statistically significant
decrease in total calories (-106.2 Kcal, SD=348.8, p=0.45). However, the Recommended Food
Score (RFS) worsened by a mean of 2.4 points (max possible score=21, SD=2.2, p=0.028),
otherwise all other variables did not change in a statistically significant manner.
In comparison, larger changes were observed in the intervention participants. At 2 months, for
instance, the PDIT increased a mean of 25.1% (SD=18.3, p<0.0001) bringing the mean PDIT to
59.1% (range=25.5% to 86.7%, SD=18.3)ix, total calories decreased a mean of 395.1 Kcals
(SD=631.1, p=0.006), saturated fat decreased 11.2 grams (SD=9.9, p<0.0001), cholesterol
decreased 146.6 mg (SD=120.6, p<0.001), dietary fiber increased 8.7 grams (SD=12.7, p=0.003),
combined fruits and vegetable servings increased by 2.6 servings (SD=3.8, p=0.003) and the
RFS increased a mean of 1.3 points (SD=3.0, p=0.038).
Similar within group changes were observed in intervention participants at both the 3 month and
9 month timepoints as outlined in the table below. In reference to the plant-based diet indexes,
the peak shift to a plant-based diet presumably occurred between the 2 and 3 month timepoint,
ix

In comparison the Plant-Based Diet Index (PDI, which equals plant calories over plant plus animal calories x 100,
and thus excludes “other” calories) increased a mean of 29.8% at 2 months to 85.5% (range=51.7 to 100%,
SD=16.3). Thus, the PDIT is likely a more conservative measure of a shift to a plant-based diet because it includes
“other” food items which could contain either plant or animal ingredients.
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although there were no statistically significant differences in dietary change variables between
any of the timepoints.

Table 3. Within Group Analysis of Change in Dietary Components
Control Changes
(n=7)†

2 Month Changes
(n=24)†

3 Month Changes
(n=24)†

Mean

SD

P
Value

Mean

SD

P
Value

Mean

SD

KCal

-106.2

348.8

0.4510

-395.1

631.1

0.0055

-273.6

Protein

-11.2

22.3

0.2328

-18.7

30.0

0.0057

-16.4

Fat

-1.6

22.9

0.8597

-27.6

30.3

0.0002

Carbohydrates

-9.7

34.0

0.4801

-11.9

85.8

0.5026

Saturated fat

-3.5

7.6

0.2679

-11.2

9.9

Cholesterol

-75.2

63.1

0.0198

-146.3

Fiber

9 Month Changes
(n=19)†

P
Value

Mean

SD

P
Value

590.6

0.0329

-313.6

675.4

0.0581

30.2

0.0141

-16.4

29.3

0.0256

-21.6

31.2

0.0026

-24.7

34.8

0.0061

4.1

67.1

0.7675

-4.2

82.0

0.8245

0.0000

-9.5

9.1

0.0000

-7.1

11.3

0.0130

120.6

0.0000

-133.2

122.1

0.0000

-91.4

129.3

0.0064
0.1396

4.1

5.5

0.0954

8.7

12.7

0.0029

10.0

13.7

0.0016

3.6

10.2

-851.0

1168.0

0.1022

684.0

3253.1

0.3137

963.3

2900.0

0.1173

835.1

2564.6

0.1729

3.0

4.5

0.1266

-5.7

9.3

0.0060

-3.5

8.8

0.0638

-2.7

7.4

0.1264

% Fat

2.1

4.6

0.2792

-5.6

8.4

0.0033

-5.7

7.1

0.0007

-7.7

9.4

0.0021

% Protein

-1.6

2.3

0.1171

-0.8

3.2

0.2218

-1.5

2.7

0.0136

-1.2

2.6

0.0658

Grams of solid food
% Sugar

% Carbohydrates

0.3

5.2

0.8714

8.3

9.5

0.0003

9.2

9.0

0.0000

10.2

10.9

0.0007

Vegetable servings

-0.1

1.6

0.8728

2.1

3.3

0.0049

2.1

2.8

0.0012

2.1

2.5

0.0020

Fruit servings

-0.4

0.9

0.3551

0.5

1.0

0.0268

0.6

0.9

0.0019

0.5

1.0

0.0412

Meat servings

-0.1

0.8

0.7254

-0.8

1.3

0.0075

-0.5

1.5

0.1011

-0.7

1.2

0.0268

Dairy servings

-0.9

1.9

0.2380

-0.6

1.3

0.0552

-0.7

1.0

0.0027

-0.4

1.1

0.1753

RFS*

-2.4

2.2

0.0407

1.3

3.0

0.0285

1.6

2.9

0.0131

1.2

2.3

0.0415

Calories from animals

-228.7

338.2

0.1237

-404.7

361.9

0.0000

-388.6

342.7

0.0000

-278.2

296.2

0.0007

Calories from plants

104.4

211.9

0.2402

294.6

419.9

0.0022

327.2

415.2

0.0008

99.3

372.7

0.2607

Calories from other

18.1

155.7

0.7686

-285.0

409.7

0.0024

-212.2

347.5

0.0065

-134.7

454.7

0.2129

PDI

11.2

11.6

0.0428

29.8

20.6

0.0000

29.9

19.3

0.0000

21.0

21.2

0.0004

PDIT

6.0

5.4

0.0260

25.1

18.3

0.0000

23.1

18.1

0.0000

14.8

19.3

0.0036

Abbreviations: Kcal, Calories in Kcal; RFS, Recommended Food Score; PDI, Plant-Based Diet Index; PDIT, Total Plant-Based Diet Index
Bold: p value is less than 0.05
†One participant’s food frequency questionnaire was excluded from analysis from both the control and intervention group because they exceeded the
number of allowable errors.
*analysis via 2-tailed Wilcoxon Singed Ranks test (all others by 2-tailed, paired, Student’s t-test)

Table 4 on the following page summarizes the between group analysis of dietary change
variables comparing the intervention group 1 at 2, 3 and 9 months to the control group. Although
the control period did overlap with the first 2 months of group 1’s intervention period, there were
statistically significant differences in time intervals (52.5 days (SD=7.5) or 4.3 weeks vs. 30.3
days (SD=8.7) or 7.5 weeks, p<0.001). Still, at 2 months, intervention group 1 demonstrated
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significantly greater reductions in total fat (-33.7 grams (SD=33.2) vs. -1.6 grams (SD=22.9),
p=0.036), saturated fat (-13.3 grams (SD=10.7) vs. -3.5 grams (SD=7.6), p=0.046) and percent of
calories from sugar (-5.2 (SD=6.9) vs. 3.0 (SD=4.5), p=0.012), as well as significantly greater
increases in the PDI (31.4% (SD=21.1) vs. 11.2% (SD=11.6), p=0.031), the PDIT (28.6%
(SD=19.2) vs. 6.0% (SD=5.4), p=0.001) and the RFS (0.6 (SD=3.2) vs. -2.4 (SD=2.2),
p=0.0496). Consistent trends were exhibited in changes in fruits and vegetable servings, meat
servings, fiber, cholesterol, and total calories but these changes were not statistically significant.
Similar changes were observed in group 1 dietary variables at 3 and 9 months as described in
Table 5 (next page). However, statistically significant change (compared with the control period)
only remained for decreases in percent fat, and increases in percent carbohydrates, fruits and
vegetable servings (9 months only), the PDI and PDIT (3 months only), and the RFS.

Table 4. Between Group Analysis of Dietary Components Change (continued next page)
Control period changes compared to Intervention Group 1 changes at
2 months
(Group 1 n=13, Control n= 7)
Kcal
Protein
Fat
Carbohydrates
Saturated Fat
Cholesterol
Fiber

3 months
(Group 1 n=13, Control n= 7)

9 months
(Group 1 n=8, Control n= 7)

Mean

SD

P Value

Mean

SD

P Value

Mean

SD

P Value

Group 1

-522.8

638.8

0.1294

-409.5

708.8

0.3051

-250.3

904.4

0.6993

Control

-106.2

348.8
0.4630

-22.6

39.5

0.4916

-17.9

39.4

0.6992

0.0357

-28.4

38.7

0.1131

-22.7

48.5

0.3139

0.5170

-8.4

68.2

0.9637

10.6

96.7

0.6083

0.0459

-11.7

10.4

0.0831

-6.8

16.2

0.6281

0.1848

-140.1

137.8

0.2568

-76.1

162.9

0.9892

0.3130

8.9

11.9

0.2423

7.1

10.1

0.5036

0.4519

116.2

3326.6

0.4705

519.9

3195.6

0.3041

0.0117

-1.8

8.4

0.1768

-1.5

8.2

0.2072

Group 1

-23.0

37.9

Control

-11.2

22.3

Group 1

-33.7

33.2

Control

-1.6

22.9

Group 1

-26.5

79.0

Control

-9.7

34.0

Group 1

-13.3

10.7

Control

-3.5

7.6

Group 1

-148.9

132.4

Control

-75.2

63.1

Group 1

8.4

12.6

Control

4.1

5.5

Grams of Solid
Food

Group 1

-84.4

3215.9

Control

-851.0

1168.0

% Sugar

Group 1

-5.2

6.9

Control
3.0
4.5
Abbreviations: Kcal, Calories in Kcal; RFS, Recommended Food Score; PDI, Plant-Based Diet Index; PDIT, Total Plant-Based Diet
Index
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Table 4 Continued. Between Group Analysis of Dietary Components Change
Control period changes compared to Intervention Group 1 changes at

% Fat
% Protein
% Carbohydrates
Fruits + Vegetable
Servings

2 months
(Group 1 n=13, Control n= 7)

3 months
(Group 1 n=13, Control n= 7)

9 months
(Group 1 n=8, Control n= 7)

Mean

SD

P Value

Mean

SD

P Value

Mean

SD

P Value

Group 1

-6.2

10.9

0.0741

-6.7

8.7

0.0238

-9.1

12.8

0.0466

Control

2.1

4.6
0.3185

-1.2

2.7

0.7517

-1.5

2.8

0.9334

0.1155

10.2

10.7

0.0345

12.9

14.2

0.0459

0.1849

2.0

3.2

0.0732

2.6

3.3

0.0471

Group 1

-0.1

3.5

Control

-1.6

2.3

Group 1

8.3

12.1

Control

0.3

5.2

Group 1

1.3

3.1

Control
-0.5
1.7
Abbreviations: Kcal, Calories in Kcal; RFS, Recommended Food Score; PDI, Plant-Based Diet Index; PDIT, Total Plant-Based Diet
Index

Table 5. Between Group Analysis of Dietary Components Change Continued
Control period changes compared to Intervention Group 1 changes at

Meat Servings
Dairy Servings
PDI
PDIT
RFS*

2 months
(Group 1 n=13, Control n= 7)

3 months
(Group 1 n=13, Control n= 7)

9 months
(Group 1 n=8, Control n= 7)

Mean

SD

P Value

Mean

SD

P Value

Mean

SD

P Value

Group 1

-0.7

1.5

0.3762

-0.5

1.8

0.5813

-0.7

1.7

0.4454

Control

-0.1

0.8
0.7670

-0.8

0.8

0.8910

-0.4

0.7

0.5116

0.0313

32.1

19.5

0.0187

24.2

22.5

0.1907

0.0013

26.0

18.0

0.0021

22.0

22.2

0.0842

0.0496

1.2

3.3

0.0145

0.5

1.8

0.0195

Group 1

-0.7

1.1

Control

-0.9

1.9

Group 1

31.4

21.1

Control

11.2

11.6

Group 1

28.6

19.2

Control

6.0

5.4

Group 1

0.6

3.2

Control
-2.4
2.2
-2.4
2.2
-2.4
2.2
Abbreviations: Kcal, Calories in Kcal; RFS, Recommended Food Score; PDI, Plant-Based Diet Index; PDIT, Total Plant-Based Diet
Index
*Between group analysis by 2-tailed, Mann-Whitney U test (all others 2-tailed, independent Student’s t-test)

As previously described, two novel dietary indexes were calculated to assess a “shift towards a
plant-based diet” as reflected by an increased proportion of calories from plant sources relatively
to total calories (the PDIT) or animal calories (the PDI). Tables 6 and 7 below describe
correlations between these scales and selected dietary changes and behavioral variables
respectively within all intervention participants at 2 months. At 2 months, increases in both
indexes were strongly and significantly correlated with decreases in saturated fat (PDI r=-.55,
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p=0.005; PDIT r=-.49, p=0.015), cholesterol (r=-.82, p<0.001; r=-.63, p=0.001) and increases in
fiber (r=.58, p<0.001; r=.61, p=0.002).
Quintiles of changes in both indexes also correlated with several related behavioral variables. At
2 months, a lower end Vegan-Omnivores Scale (VOS) score (i.e. closer to 1 or Vegan) correlated
with a higher quintile of each index (rs=-.67, p<0.001; rs=-.72, p<0.001) as did a change in the
VOS score (rs=-.68, p<0.001; rs=-.56, p=0.004). 2 month self-efficacy scales also correlated with
quintiles of each index. A high self-efficacy to eat les animal products (rs=.65, p=0.001; rs=.61,
p=0.002), to shop for or prepare vegan meals (rs=.43, p=0.039; rs=.60, p=0.002), and to eat a
vegan diet despite the challenges this might pose (rs=.36, p=0.087; rs=0.62, p=0.001) correlated
with a high quintile of the plant-based indexes. Similarly, high motivation to eat a plant-based
diet (rs=.44, p=0.034; rs=0.62, p=0.001) and low resistance to eating a plant-based diet (rs=-.29,
p=0.175; rs=-45, p=0.028) correlated with a high quintile of both dietary indexes.

Table 6. Correlations Between Changes in Plant-Based Diet Indexes and
Selected Dietary Variables at 2 Months*
PDI

PDI
PDIT

PDIT

Correlation
Coefficient
1.000

P Value
.

Correlation
Coefficient
0.834

P Value
0.000

0.834

0.000

1.000

.

Kcal

-0.113

0.600

-0.133

0.536

Fat

-0.324

0.123

-0.317

0.132

Carbohydrates

0.229

0.282

0.149

0.486

Saturated Fat

-0.553

0.005

-0.489

0.015

Cholesterol

-0.818

0.000

-0.628

0.001

Fiber

0.577

0.003

0.608

0.002

Fruits + Vegetables Servings

0.377

0.069

0.364

0.081

Meat Servings

-0.329

0.117

-0.135

0.529

End RFS Score†
0.303
0.150
0.484
0.016
Abbreviations: PDI, Plant-Based Diet Index; PDIT, Total Plant-Based Diet Index; Kcal, Calories in
Kcal; RFS, Recommended Food Score
*n=24
†Analyzed by Spearman correlation (all others by Pearson correlation)
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Table 7. Correlations between Quintile of Changes in Plant-Based Diet
Indexes and Selected Behavioral Variables at 2 Months*
PDI
Correlation
Coefficient
End VOS†
VOS Change
Self Efficacy to:
Eat less Animal Products

P Value

PDIT
Correlation
Coefficient
P Value

-0.668

0.000

-0.722

0.000

-0.675

0.000

-0.564

0.004

0.647

0.001

0.611

0.002

Shop for/Prepare vegan meals

0.425

0.039

0.602

0.002

Eat a vegan diet despite
challenges

0.357

0.087

0.622

0.001

0.435

0.034

0.616

0.001

Motivation

Resistance
-0.286
0.175
-0.447
0.028
Abbreviations: VOS, Vegan-Omnivore Scale; PDI, Plant-Based Diet Index; PDIT, Total Plant-Based
Diet Index
†All variables analyzed by Spearman correlation; *n=24

Change in Activity Level
Within group changes in activity level were assessed in both the control and intervention periods
by the modified Yale Physical Activity Survey (YPAS). Physical activity was also measured by
RT3 accelerometers (as described in the methods section) in all intervention participants at 3 and
9 months. Table 8 below describes within group changes in YPAS in the control period and in all
intervention participants at 2, 3 and 9 months. No significant changes in YPAS score were
observed. Table 8 also describes within group changes in vector measurements derived from the
RT3 accelerometers. Here again, no significant within group changes were observed with the
exception of a mean decrease of 22.86 vector units (SD=39.64, p=0.02) in intervention
participants at 9 months.
Table 8. Within Group Change in activity measures
Control
n=7*

2 Months
n=23*

3 Months
n=23*

9 Months
n=19*

Change in

Mean

SD

P
Value

Mean

SD

P
Value

Mean

SD

P
Value

Mean

SD

P
Value

YPAS

1.57

11.3

0.724

1.04

17.1

0.773

4.74

20.5

0.280

-1.82

19.7

0.708

4.57
36.4 0.535 -22.86 39.6 0.022
Vector Measure
Abbreviations: YPAS, modified Yale Physical Activity Survey
* 2 YPAS change scores could not be calculated at 2 and 3 month timepoints and 1 change score in the control period and at 9 months because of
incomplete surveys. The n for the accelerometer vector measurements was 25 at 3 months and 19 at 9 months.
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Correlations between weight and activity level changes are described in the following section.

Change in Weight
Table 9 below describes within group changes in weight and related measures. Over the control
period, weight increased on average 1.25 Kg or 2.8 lbs (SD=1.35 Kg, p=0.035). Among
intervention participants weight decreased on average 1.54 Kg or 3.4 lbs (SD=2.25 Kg, p=0.002)
after 2 months, 2.66 Kg or 5.9 lbs (SD=3.5 Kg, p=0.001) after 3 months and 4.02 Kg or 8.8 lbs
(SD=6.43, p=0.012) after 9 months. Similar statistically significant changes were also observed
in body mass index (BMI) and percent of body weight lost. Physical activity as measured by
survey and activity monitor did not reveal significant within group changes except for a decrease
in activity observed by accelerometer changes at 9 months as described above.

Table 9. Within Group Change in Weight and related variables
Control
n=8*
Change in
Weight (Kg)

2 Months
n=26*

3 Months
n=25*

9 Months
n=20*

Mean

SD

P
Value

Mean

SD

P
Value

Mean

SD

P
Value

1.25

1.35

0.035

-1.54

2.25

0.002

-2.66

3.50

P
Value

0.001

Mean
-4.02

SD
6.43
2.34

0.010

0.012

Body Mass Index (Kg/m )

0.55

0.86

0.112

-0.63

0.86

0.001

-1.02

1.29

0.001

-1.50

Percent Body Weight

1.29

1.27

0.024

-1.57

2.10

0.001

-2.44

3.13

0.001

-3.80

6.02

0.011

YPAS

1.57

11.25

0.724

1.04

17.12

0.773

4.74

20.50

0.280

-1.82

19.73

0.708

2

Vector Measure
4.57
36.36
0.535
-22.86 39.64
0.022
Abbreviations: YPAS, modified Yale Physical Activity Survey
* n for YPAS was 7 for the control period, 23 at 2 and 3 months and 19 at 9 months. The n for the accelerometer vector measurements was 25 at
3 months and 19 at 9 months.

Figure 13 on the following page displays mean changes in body weight (lbs) among control
participants and intervention participants at 2, 3 and 9 months.
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Figure 13. Mean Weight Change in Control vs. All Participants
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An intention to treat analysis was performed on 9 month (within group) changes among
intervention participants by carrying forward the previous (i.e. 3 month) values of the 5
participants that dropped out or discontinued the follow-up study. In this analysis, weight
decreased a mean of 3.54 Kg or 7.8 lbs (SD=6.06 Kg, p=0.008).

Table 10. Intention to Treat Analysis on
within group 9 Month Changes
9 Months
(n=25)
Change in

Mean

SD

P Value*

Weight (Kg)

-3.54

6.06

0.008

-1.31

2.23

0.007

Percent Body Weight
-3.26
*2-tailed, paired, Student’s t-test

5.63

0.008

2

Body Mass Index (Kg/m )

Table 11 on the following page describes changes in weight and related measures in the control
period as compared to intervention group 1 change at 2, 3 and 9 months. At 2 months, group 1
lost an average of 2.2. Kg (SD=2.1) compared to a gain of 1.3 Kg (SD=1.4) in the control period,
p=0.0006. Similar differences were seen in BMI, p=0.0013 and percent body weight lost,
p=0.0004 at 2 months. Physical activity as measured by the modified Yale Physical Activity
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Survey did not reveal significant differences at the 2 month timepoint compared to the control
period (4.3 (SD=14.8) vs. 1.6 (SD=11.3), p=0.97).

Table 11. Between Group Analysis of Weight Change and Activity Change
Control Period Changes compared to Intervention Group 1 Changes at
2 months
(Group 1 n=13, Control n=8)

3 months
(Group 1 n=13, Control n=8)

9 months
(Group 1 n=8, Control n=8)

Mean

SD

P Value

Mean

SD

P Value

Mean

SD

P Value

Group 1

-2.2

2.1

0.0006

-3.1

3.6

0.0040

-5.6

8.8

0.0632

Control

1.3

1.4

Group 1

-0.9

0.8

0.0013

-1.0

1.5

0.0131

-1.9

3.3

0.0764

Control

0.6

0.9

Group 1

-2.2

2.0

0.0004

-2.9

3.3

0.0029

-5.5

8.1

0.0494

Control

1.3

1.3

Group 1

4.3

14.8

0.9671

7.7

22.6

0.2268

3.7

22.0

0.2496

Control

1.6

11.3

Change in
Weight (Kg)
Body Mass Index (Kg/m2)
Percent Body Weight
YPAS

Abbreviations: YPAS, modified Yale Physical Activity Survey

Correlations between within group changes in weight and dietary changes are described in Table
12 (on the following page) for intervention participants at all timepoints. At 2 months, weight
change only correlated significantly with a change in Vegan-Omnivore Scale (rs=.40.p=-.048).
At 3 months, a decrease in weight was significantly correlated with an increase in percent
carbohydrates (r=-.55. p=.005), an increase in combined fruits and vegetable servings (r=-.50,
p=0.014), a decrease in meat servings (r=.42, p=.044), and an increase in both PDI (r=-.43,
p=0.038) and PDIT (r=-.47, p=0.020). At 9 months, a decrease in weight was significantly
correlated to a decrease in dietary cholesterol (r=.56, p=0.012), a decrease in calories from
animal products (r=.58, p=0.010), a decrease in the Vegan-Omnivore Scale (i.e. a shift to vegan,
rs=.74, p<0.001) and an increase in both the PDI (r=.49, p=0.035) and PDIT (r=-.50, p=0.031).
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Table 12. Within Group Correlations between Weight Change and Dietary Variables
Changes in Weight at
2 months
(n=24)
Correlation
Coefficient
P Value
0.062
0.775

Change in
Kcal

3 months
(n=24)
Correlation
Coefficient
P Value
0.187
0.382

9 months
(n=19)
Correlation
Coefficient
0.297

P Value
0.217

Protein

0.034

0.876

0.343

0.101

0.369

0.120

Fat

0.064

0.766

0.211

0.322

0.252

0.297

Carbohydrate

0.019

0.928

-0.056

0.795

0.194

0.425

Saturated Fat

0.079

0.712

0.264

0.213

0.391

0.097

Cholesterol

-0.142

0.509

0.349

0.095

0.563

0.012

Fiber

-0.088

0.682

-0.312

0.138

-0.276

0.252

% Sugar

0.043

0.843

-0.039

0.855

0.101

0.681

% Fat

0.285

0.176

0.382

0.066

0.039

0.874

% Protein

-0.068

0.753

0.377

0.069

0.365

0.124

% Carbohydrate

-0.312

0.137

-0.551

0.005

-0.271

0.262

Fruits + Vegetable Servings

-0.097

0.651

-0.496

0.014

-0.260

0.283

Meat Servings

-0.154

0.471

0.415

0.044

0.444

0.057

Calories from animals

-0.012

0.956

0.359

0.085

0.576

0.010

Calories from plants

-0.05

0.817

-0.079

0.714

-0.167

0.494

Calories from other sources

0.156

0.466

0.058

0.789

0.203

0.405

PDI

-0.132

0.540

-0.426

0.038

-0.487

0.035

PDIT

-0.347

0.096

-0.471

0.020

-0.496

0.031

RFS†

0.046

0.832

0.463

0.023

0.011

0.965

VOS*†
0.399
0.279
0.177
0.740
0.048
0.000
Abbreviations: Kcal, Calories in Kcal; PDI, Plant-Based Diet Index; PDIT, Total Plant-Based Diet Index; RFS, Recommended Food
Score; VOS, Vegan-Omnivore Scale
*n= 25 at 2 months, 25 at 3 months, 19 at 9 months;
†test is Spearman Correlation on Quintiles of Weight Change (all others are Pearson Correlation on Weight Change)

Changes in activity as measured by both survey (YPAS) and RT3 accelerometer did not correlate
with changes in weight (or related measures) at any timepoint as described in the Table 13.

Table 13. Correlations between within group changes in activity measures and weight measures

Quintile of
Change in

Control
period
(n=7)

Intervention Group at
2
3
9
months
months
months
(n=23)
(n=23)
(n=17)
YPAS
-0.034

Weight

Correlation Coefficient

YPAS
0.060

P Value*

0.899

0.879

0.391

0.6283

BMI

Correlation Coefficient

0.401

0.077

-0.101

-0.1567

P Value*

0.373

0.725

0.647

0.5482

% Body
Weight

YPAS
-0.188

YPAS
-0.1266

Correlation Coefficient

0.060

0.029

-0.119

-0.2168

P Value*

0.899

0.897

0.589

0.4032

Intervention
Group at
3
9
months
months
(n=25)
(n=19)
Change in

VM
-0.063

VM
0.103

P Value†

0.765

0.674

Correlation Coefficient

-0.156

0.065

P Value†

0.456

0.792

Correlation Coefficient

-0.114

0.054

P Value†

0.588

0.826

Weight

Correlation Coefficient

BMI
% Body
Weight

Abbreviations: BMI, Body Mass Index; YPAS, modified Yale Physical Activity Survey; VM, average daily Vector Measurement from RT3
accelerometer
*test is Spearman Correlation on quintiles of continuous variable change vs. change in YPAS
†test is Pearson Correlation on continuous variable change vs. change in VM
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Finally, logistic regression was performed on weight change and BMI change for the control
period and the intervention group at 2 months. After adjustment for activity changes (as
measured by the YPAS), gender, race, age, education level and household income, weight
change for the control period was 0.86 Kg (SD=2.8, within group change p=0.24) compared with
-1.4 Kg (SD=3.0, p=0.009). This difference between group remained statistically significant,
p=0.01. Similar results were found for BMI change after adjustment for the same factors. BMI
change for the control period was 0.41 Kg/m2 (SD=1.3, p=0.20) compared with -0.58 Kg/m2
(SD=0.002). This difference between group remained statistically significant, p=0.01.

Change in Body Composition
Body composition was assessed by Duel Energy X-Ray Absorptiometry (DEXA Scans) on all
participants at baseline, 3 months and 9 months. However, the DEXA scanner is limited in its
width of scan and is only standardized up to 300 lbs. Thus, scans that did not fit comfortably
within the limits of the machine or scans on patients weighing 300 lbs or more were excluded
from analysis.
Within group decreases were observed in total fat mass, total lean mass, and total tissue mass at
3 and 9 months. Changes in total fat mass did not reach significance. Decreases in lean mass
decreased significantly at both 3 and 9 months (-2810 grams (SD=1777.5), p<0.001 and -2869.8
grams (SD=3502.1), p=0.016). Note that lean mass includes both visceral and skeletal muscle,
and that it may include some peri-visceral and intra-muscular fat. Total tissue mass also
decreased significantly at both timepoints (-2810.4 grams (SD=2809.6), p=0.001 and-5815.2
grams (SD=7294.7), p=0.019). Increases were observed in total bone mineral content but these
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were not statistically significant. Percent fat did not change significantly at 3 months, but
decreased by 1.8% (SD=2.8) at 9 months, p=0.043.

Table 14. Within Group Changes in DEXA Scan Variables
Intervention Participant Changes at
3 months
(n=16)
Change in:
Total fat mass (g)

Mean
-634.5

9 months
(n=12)

SD
2805.8

P Value
0.380

Mean
-2945.3

SD
5269.6

P Value
0.079

Total lean mass (g)

-2175.6

1777.5

0.000

-2869.8

3502.1

0.016

Total tissue mass (g)

-2810.4

2809.6

0.001

-5815.2

7294.7

0.019

Total BMC (g)

75.6

164.1

0.085

99.3

278.8

0.243

Total % fat mass

0.8

2.1

0.164

-1.8

2.8

0.043

Abbreviations: BMC, Bone Mineral Content; g, grams

Change in Blood Pressure
Since some patients were mildly hypotensive at baseline, within group changes in blood pressure
were analyzed in control and intervention participants with above normal average baseline blood
pressure, i.e. a systolic blood pressure (SBP) > 120 mmHg or a diastolic blood pressure (DBP) >
80 mmHg. Findings are found in the table on the following page. Both control (n=6) and
intervention participants (n=20 at 3 months, n=15 at 9 months) experienced a reduction of
systolic blood pressure, whereas only the intervention group experienced a reduction in diastolic
blood pressure. The control SBP decreased a mean of 5.4 mmHg (SD=18.6, p=0.5). The
intervention SBP decreased a mean of 8.7 mmHg (SD=15.5, p=0.02) at 3 months and 7.5 mmHg
(SD=12.8, p=0.04) at 9 months. The control mean DBP did not change significantly (0.2 mmHg,
SD=10, p=0.95). The intervention DBP decreased a mean of 5.9 mmHg (SD=10.6, p=0.02) at 3
months and 3.5 mmHg (SD=9.4, p=0.17) at 9 months.

63
Table 15. Within Group Analysis of Changes in Blood Pressure in Participants with Baseline
SBP>120 or DBP>80
Changes within control or intervention participants

Change in mean:

Control

3 months

(n=6)

(n=20)

Mean

SD

P Value

Mean

SD

-5.4

18.6

0.505

-8.7

15.5

Diastolic blood pressure*
0.2
10.0
0.954
-5.9
Abbreviations: SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure
* units: millimeters of mercury

10.6

Systolic blood pressure*

9 months
(n=15)
P Value

Mean

SD

P Value

0.022

-7.5

12.8

0.040

0.022

-3.5

9.4

0.172

Between group analysis was also conducted on the subset of control (n=6) and intervention
group 1 (n=10) participants with an average baseline SBP >120 or a DBP >80. At 3 months,
group 1 SBP decreased on average 14.5 mmHg (SD=13.7) and DBP decreased 7.1 mmHg
(SD=12.9). At 9 months, group 1 SBP decreased on average 17.1 mmHg (SD=9.5) and DBP 5.4
(SD=9.6). However, compared with control changes none of these differences were statistically
significant as described in Table 16 on the following page.

Table 16. Between Group Analysis of Changes in Average Blood Pressure in Participants with
Baseline SBP>120, or DBP>80
Control changes compared to intervention group 1 changes at

Change in mean:
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)

3 months

9 months

(Group 1 n=10, control n=6)

(Group 1 n=5, control n=6)

Mean

SD

P Value

Mean

SD

P Value

0.278

-17.1

9.5

0.238

0.256

-5.4

9.6

0.369

Group 1

-14.5

13.7

Control

-5.4

18.6

Group 1

-7.1

12.9

Control
0.2
10.0
Abbreviations: SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure ; mmHg, millimeters of mercury

Change in Lipids
Fasting blood lipids were measured at baseline, 3 and 9 months on intervention participants only.
Table 17 below describes within group changes at 3 and 9 months for participants with one or
more criteria for a dyslipidemia, i.e. total cholesterol >200, or LDL cholesterol >130, or HDL

64
cholesterol <40, or triglycerides >150, at 3 months (n=15) and at 9 months (n=11). Within group
changes were only statistically significant for a reduction in HDL (and HDL ratios) at 3 months
(-7.73 mg/dl, SD=6.95, p=0.001) and at 9 months (-5.0 mg/dl, SD=6.05, p=0.021).

Table 17. Within Group Analysis of Changes in Blood Lipids in
Intervention Participants with a Baseline Dyslipidemia
3 months
(n=15)
Change in
TCHL

Mean
-6.27

9 months
(n=11)

SD
20.53

P Value
0.257

Mean
-9.27

SD
35.05

P Value
0.401

HDL

-7.73

6.95

0.001

-5.00

6.05

0.021

LDL

-1.33

20.13

0.801

-4.73

30.08

0.614
0.857

VLDL

2.80

11.95

0.380

0.45

8.13

TG

14.53

60.50

0.368

0.73

40.90

0.954

TCHL/HDL

0.63

0.74

0.005

0.34

0.94

0.262

LDL/HDL

0.40

0.48

0.006

0.24

0.84

0.358

Abbreviations: TCHL, Total Cholesterol; HDL, High Density Lipoprotein cholesterol; LDL,
Low Density Lipoprotein cholesterol; VLDL, Very Low Density Lipoprotein cholesterol;
TG, Trigylcerides

Table 18 below describes within group changes at 3 months for the subset of intervention
participants who lost 5% or more of initial body weight (n=4). Within group changes were
significant for a reduction in total cholesterol of 39.3 mg/dl (SD=21.3, p=0.034) and a reduction
in HDL (and related ratios) of 18.0 mg/dl (SD=5.8, p=0.009).

Table 18. Within Group Analysis of Changes
in Blood Lipids in Intervention Participants
with 5% or More of Body Weight Lost
3 months
(n=4)
Change in
TCHL

Mean
-39.25

SD
21.27

P Value
0.034

HDL
LDL

-18.00

5.83

0.009

-22.00

23.08

0.153
0.789

VLDL

0.75

5.12

TG

3.50

28.24

0.820

TCHL/HDL

0.38

0.54

0.262

LDL/HDL

0.21

0.54

0.499

Abbreviations: TCHL, Total Cholesterol; HDL, High Density
Lipoprotein cholesterol; LDL, Low Density Lipoprotein
cholesterol; VLDL, Very Low Density Lipoprotein cholesterol;
TG, Trigylcerides
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Change in Glycemic Control
Glycemic control was assessed in intervention participants by measuring fasting blood sugar, and
glycosylated hemoglobin (Ha1c) at baseline, 3 and 9 months. Table 19 below describes within
group changes in participants with diabetes or “pre-diabetes”, i.e. a baseline fasting glucose of
100 mg/dl or higher, at 3 and 9 months. A reduction in fasting glucose was observed at both 3
and 9 months (-17 mg/dl, SD=33.1, p=0.16; and -8.2 mg/dl, SD=24.5, p=0.45) but these changes
were not significant. Glycosylated hemoglobin did not change significantly at 3 months but
increased on average 0.55% (SD=0.29, p=0.006) at 9 months.
Table 19. Within Group Analysis of Glycemic Changes in Participants
with Baseline Fasting Glucose > 100
3 month

9 month

(n=9)

(n=6)

Change in

Mean

SD

P Value

Mean

SD

P Value

Fasting Glucose

-17.00

33.05

0.161

-8.17

24.50

0.451

0.133

0.55

0.29

0.006

0.16
0.28
Ha1c
Abbreviations: Ha1c, glycosylated hemoglobin

Intervention Attendance and Satisfaction
The intervention was given twice, as described above. Average attendance for both groups (n=14
and n=15 at baseline) was 12 participants per session (standard deviation, SD=1.5).
Satisfaction with the study intervention was assessed by both anonymous post-session
satisfaction surveys and by a non-anonymous post-intervention survey. As detailed in Figure 14
on the following page anonymous surveys assessed perceived importance of each of the 6
sessions by asking on a scale of 0 to 7 “How important was the information or facts taught in
this session to you?” The mean response for all participants and all sessions was 6.22 (SD=0.98,
max=7, min=2). Similarly, satisfaction with the learning experience offered by each session was
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assessed by asking on a scale of 0 to 7 “How satisfied where you with this session as a learning
experience?” The mean response for all participants and all sessions was 6.20 (SD=1.10, max=7,
min=2).

Figure 14. Average Perceived Importance and Satisfaction with All Intervention Sessions

Distinct components of each session were also evaluated by anonymous post-session surveys by
asking on a scale of 0 to 7 “How much will the information or facts about X covered in this
session help you make healthier or “more-informed” food choices?” (where X is each separate
component) On average the highest ranked component was “Animal Ethics” with a mean of 6.2
(SD=1.0, min=4, max=7). All components were ranked roughly 6.0 or above. A 2-tailed, MannWhitney U test on the components did not reveal statistically significant differences between the
components. Table 20 on the following page summarizes these results.
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Table 20. Descriptives of Anonymous Satisfaction Ratings of Program
Components
Component

N*

Min

Max

Mean

SD

P Value†

Animal Ethics

57

4

7

6.19

1.0

-

Health, Obesity or Nutrition

139

2

7

6.16

1.0

0.919

Practical Components

37

4

7

6.08

0.9

0.502

All Socio-political Components

140

1

7

6.07

1.1

0.634

Environmental

40

3

7

6.03

1.2

0.641

Food Politics

43

1

7

5.95

1.3

0.447

*N is the number of survey responses addressing each component, e.g. if 20 participants attended Sessions # 2
and 4 which covered environmental topics, this gives an N or 40 responses.
†Test is 2-tailed, Mann-Whitney U comparing “animal ethics” to each other component.

A non-anonymous post-intervention survey asked participants to rate each component on a scale
of 0 to 7 as to “How valuable or important was it for you to learn about how X in this
program?” (where X is each separate component). On average, the highest ranked component
was “how food affects your health” with a mean of 6.76 (SD=0.5, min=5, max=7). All program
components, with the exception of “fast food and food politics” (mean=5.72, SD=1.9) ranked
above 6.0. A 2-tailed Wilcoxon Signed Ranks test revealed a statistically significant difference
between the health component and “animal ethics”, “all socio-political components combined”,
and “fast-food and food politics” as summarized in Table 21 below.

Table 21. Descriptives of Non-Anonymous, Post-Intervention Perceived
Importance of Program Components
Component

N

Min

Max

Mean

SD

Health

25

5

7

6.76

0.5

-

Obesity

25

5

7

6.52

0.8

0.250

Group Experience

25

4

7

6.48

0.8

0.148

Animal Ethics

25

4

7

6.44

0.8

0.008

Practical Components

25

4

7

6.36

1.0

0.078

All Socio-political Components

25

4

7

6.24

0.9

0.001

Environmental

25

4

7

6.16

0.9

0.001

1.9

0.007

Fast Food, Food Politics
25
0
7
5.72
*test is 2-tailed Wilcoxon Signed Ranks comparing “health” to each other component

P Value*
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DISCUSSION
This study aimed to pilot a novel approach to facilitating dietary change in obese adults.
Specifically, the study intervention (i.e. a vegan healthy eating program) consisted of a group
dietary educational program that departed from the traditional model of discussing diet solely in
relation to health and disease. Instead, approximately two-thirds of the 6 weekly educational
sessions focused on the impact of dietary choices on the environment, the current treatment of
farm animals and the socio-political implications of the fast-food and animal agricultural
industries.

Feasibility and Satisfaction
There were three anticipated barriers existed to implementing this type of intervention. First, it
was not known whether patients seen in a university-based ambulatory setting would be willing
to participate in a vegan healthy eating program and undergo the inconveniences associated with
being a research participant. Yet roughly 15% of patients contacted (in person or by mail)
expressed desire to participate in our study. After screening for inclusion and exclusion criteria
we enrolled just over 10% of patients contacted. Every patient that met inclusion and exclusion
criteria enrolled in the study. These rates demonstrate that some patients are in fact interested in
participating in such an intervention, at least in a research setting. Financial compensation for
participation was minimal ($45 to $60 over a 3 month period) and we do not believe this
contributed to successful recruitment efforts.
Second, it was not known how patients would react towards the content examined in our vegan
healthy eating program. We were especially concerned about untoward reactions to discussions
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concerning intensive confinement animal agriculture (or “animal ethics”). However, in
anonymous post-session surveys the animal ethics components ranked higher than any other
component (including health, obesity and nutrition related components) for perceived importance
and satisfaction. In fact, all components of the program were highly rated (6 or higher out of 7)
and no statistical difference was observed between components. Interestingly though, in a nonanonymous post-intervention survey assessing perceived importance the health component was
rated highest followed by obesity, the group experience, and animal ethics. This time there was a
statistically significant difference between health and animal ethics related components, although
all components were again rated highly. From these results we can conclude that in this selfselected patient population, discussions of animal ethics and other non-health related dietary
topics can be perceived to constitute a positive learning experience. We can also conclude that all
components on the vegan healthy eating program were valued highly. However, since different
lecturers covered different components, it can not be known whether the subtle perceived
differences between components was attributable to the delivery or the content of each
component. Response rates were close to 100% for both anonymous and non-anonymous
surveys and thus we do not think a response bias existed. If anything, the survey questions used
to assess perceived importance biased respondents towards rating health-related components the
most favorably (as the questions asked how each component would enable the respondent to
make “healthier or more-informed food choices”). The high ratings of non-health related
components were thus consistent with our hypothesis that these components can be successfully
incorporated into a dietary change program.
Third, given the sensitive nature of the topics discussed, it was not known whether the
intervention would foster a high degree of recidivism. 4 out of the initial 29 participants dropped
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out of the 3 month study. We were satisfied with this outcome as we anticipated 5 dropouts in
our sample size calculations. 20 out of the remaining 25 participants elected to continue with the
study after 3 months. We had no apriori expectations about retention after 3 months but again
feel that this rate is acceptable given that few dietary interventions are effective for all
participants and that dropouts are an inevitable reality in clinical research. Thus we feel that
recidivism observed was within the normal limits of behavioral research standards and does not
reflect a major concern with the study intervention.

A shift towards a plant-based diet?
This pilot study was designed to detect within group changes in selected dietary variables as well
as between group differences in change in the recommended food score (RFS) – a measure of
dietary pattern quality. The main goal of the study intervention was to facilitate a “shift towards
a plant-based dietary pattern” in intervention participants. Interestingly, control participants
exhibited changes in dietary pattern (in a plant-based direction) that may have stemmed from
enrolling in the study. However, these changes were smaller than those observed in intervention
participants and with the exception of a worsening of the RFS by 2.4 points (max=21) were not
statistically significant. However, it is possible that a lack of statistical power contributed to this
result.
In contrast, within group changes among intervention participants demonstrated statistically
significant changes consistent with a shift towards a plant-based diet, including reductions in
total calories, fat, saturated fat, dietary cholesterol, meat and dairy servings and increases in
fruits and vegetable servings, fiber and the recommended food score. Both plant-based dietary
indexes also increased significantly. For example, the Plant-based Diet Index (PDI, the
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proportion of total food calories derived from plant source, where only foods that could be
clearly labeled as being of either plant or animal origin where included in the denominator)
increased by 30% at 2 and 3 months and 21% at 9 months compared to baseline.
A comparison between intervention group 1 at 2 months and the control group revealed
statistically significant differences in fat, saturated fat, percent of calories from sugar, the
recommended food score and both plant-based diet indexes. Here again, though, statistical power
likely limited these observations as we employed a fairly conservative statistical approach
(excluding participants whose group did not overlap in time and thus substantially limiting our
sample size). Still, this suggests that changes observed in intervention participants were related
to participating in the study and/or the study intervention (i.e. the vegan healthy eating program),
rather than random dietary fluctuations or the effect of simply enrolling in the study.
Dietary changes were preserved throughout the study period, at least among participants who
remained in the study (n=20 out of 29 enrolled, or 70% of the original sample). There were no
statistically significant differences between changes in dietary variables at 2, 3 or 9 months.
However, with the exception of a decrease in % fat and increase in % carbohydrates, all other
dietary variables changed maximally at either the 2 or 3 month timepoint. This suggests that the
maximal degree of dietary change occurred between the 2 and 3 month point (i.e. at the end of
the study intervention) but also that despite a minimal amount of post-intervention support,
dietary changes were maintained to a significant degree up until the end of the study. Support for
this conclusion also comes from observations of weight loss (discussed below) which progressed
throughout the study period.
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It is not known whether changes observed at 2 and 3 months could have been furthered or better
maintained had more support or a continued educational intervention been offered. Since,
support is a well-recognized enhancer of plant-based dietary change150 and maintenance and
because the degree of change is typically proportional to the intensity of intervention,45, 55, 56 it is
more likely than not that 9 month changes could have been even greater if a more intensive
intervention was offered.
Although, a sub-maximal shift of dietary pattern likely occurred during the study intervention
period, it is unlikely that a maximal shift to a whole foods, low-fat, plant-based dietary pattern
was achieved. For example, percent of calories from fat moved from a baseline mean of 39.3%
to 34.0% at 2 months. This is a relatively small (although potentially meaningful) shift relative to
more intensive interventions that have achieved a mean of less than 10% of calories from fat.137
Saturated fat, however, decreased from a mean of 24 grams to 13.3 grams at 2 months, and
combined fruits and vegetable servings increased from 6 servings (considerably higher than the
national averagex) to 8.6 (near the recommended maximal goal of 9 servings). We also saw a
significant change in both our plant-based diet indexes although not a maximal change. The
PDIT (the more conservative of the two measures - the proportion of plant-calories out of all
calories - which excludes ambiguous and clearly established deleterious items from the
numerator) increased from a baseline mean of 34.4% to 59.1% at 2 months. The recommended
food score, however, only increased on average from 8.7 to 9.8 points at 2 months (p=0.04, max
possible =21 points). Thus, while meaningful change likely occurred, maximal change likely did
not.

x

In 1994-1996, only 28% of the US population ate 2 or more servings of fruit, and only 49% ate 3 or more servings
of vegetables per day.184
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An explanation for this observation can be attributed to at least 6 factors: 1. our intervention was
tailored to each group but not (to a large degree) to each individual. One-on-one dietary
counseling, for example, may have been useful at maximizing change within each individual and
thus within the group as a whole; 2. Our intervention sought to change individual perceptions
and dietary habits but did nothing to address the environment in which dietary patterns play out.
For instance, we did not go into our participants’ homes or workplaces to help improve their
daily nutritional environment; 3. Family support, which is known to aid efforts at initiating and
maintaining dietary change,150 was not incorporated into our intervention; 4. Our intervention
was not maximally intense as only 6 educational sessions and 4 maintenance sessions were held
over the 9 month period; 5. Our ability to detect dietary change was limited by the outcome
measures utilized (i.e. a food frequency questionnaire) as discussed below; and 6. We did not
offer participants a structured dietary plan (e.g. daily menus, pre-prepared meals, etc.) but instead
sought to educate our participants about diet in a broad sense and then to observe what change
would result from this effort alone.
There were 3 major constraints limiting our ability to accurately detect dietary change in this
study (2 of which apply to all our observations). First was our use of a food frequency
questionnaire (FFQ). FFQs, and indeed all dietary measures, are notorious for underreporting
dietary intake. For example, in our study, baseline total calories (as reported by FFQ) were found
to be 1968 Kcals (SD=655). Given that our study participants had a mean baseline BMI of 40.4
Kg/m2 (placing them just above the class 3 or “severely” obese cutoff), this caloric value can
only be consistent with the measured BMI by one of three mechanisms: 1. The FFQ value is too
low and reflects substantial underreporting of dietary intake for whatever reason; 2. The value is
accurate and suggests that participants had acutely lowered their dietary intake just prior to the
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study; and/or 3. The value is accurate and participants have extraordinarily low daily activity
levels. With the exception of the last reason (which we believe may reflect reality for two-three
participants at most), either of the first two reasons would have limited our ability to detect
dietary change attributable to our intervention. A 3-7 day food diary would have allowed for
more accurate reporting, but this was not feasible given resource limitations for this pilot trial.
Still, all self-reported dietary intake measures are subject to social reporting bias. (Whereas most
other established methods that do rely on self-report do not allow for real-world observation)
Thus, we made a sincere attempt to minimize social reporting bias by repeatedly explaining (in
depth) the importance of honest reporting to our research participants (both to the group and to
each individual at each data collection session). However, our study intervention was designed to
influence the social bias of the group towards plant vs. animal products. If successful, this effort
would be predicted to effect both reporting of intake and actual intake, but possibly to differing
degrees.
Second, our sample size was small leading to increased likelihood of type 2 error (i.e. a real
change occurred but we could not detect it). Still, we felt the total n was appropriate given the
pilot nature of this program and appeared to be sufficient to capture some degree of change at
least.
Third, our control arm was both small in size (n=8) and duration (t=4.3 weeks). This is clearly a
major limitation but it is not unique to our study. Participants in obesity behavioral studies (or
other lifestyle modification trials) will rarely remain in a long-term no-treatment arm. This
problem can be solved by a comparative randomized trial, but this required resources that were
not available for this pilot study.
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Perceived Dietary Change
In this study, a relatively simple measure of perceived dietary pattern, the Vegan-Omnivore
Scale (VOS), demonstrated changes consistent with dietary change measured by the more
elaborate food frequency questionnaire. Here again, the control group exhibited a small but nonsignificant shift towards a vegan or plant-based diet (moving 1.4 points to a mean of 7.2 on this
10 point scale, where 1=vegan, 10=omnivore, p=0.14) whereas the intervention group moved 5.4
points after 2 months to a mean of 2.3 (p<0.001). Mean VOS change at each timepoint also
supports our conclusion that peak change among intervention participants likely occurred
between 2 and 3 months.
At 2 months, the VOS correlated modestly with several (but not all) expected dietary variables
such as cholesterol (rs=0.51), fiber (rs=-0.43), and the plant-based diet indexes (e.g. PDI rs=0.68) and, importantly, with weight change (rs=-0.40). Similar results were found at other
timepoints as well as with change in dietary category (another marker of perceived dietary
change). In these analyses a Spearman correlation was calculated on quintiles of dietary change
variables and weight, and this conservative approach may have limited our observations. Still,
these simple measures of dietary pattern appeared rather robust in this study and their use in
future studies seems warranted.
In some ways this is a surprising conclusion, because self-reported dietary categories are usually
vague representations of reality at best. For example, in a recent review article, it was reported
that up to two-thirds of self-reported ‘vegetarians’ eat meat, fish or poultry on a regular basis.66
However, the scales used in our study included detailed definitions of each dietary category or
pattern, which may account for our results.
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Novel Dietary Indexes
Although the phrase is often used, there exists no standard definition for a “shift to a plant-based
diet” nor any standardized measure to quantify this shift. Thus, we began development of two
indexes, which we named the Plant-based Diet Index (PDI) and the Total Plant-based Diet Index
(PDIT). We defined these scales prior to collecting data on our participants with the hope that
changes in these scales would a) be observed, and b) correlate with other desired changes.
As described above, significant changes were observed in both indexes at all timepoints. These
changes were also statistically significant when compared to those observed in the control
period. Both indexes suggested that the intervention effected a sub-maximal but significant shift
towards a plant-based diet by facilitating a reduction in intake of foods of animal-origin and/or
and increase in intake of foods of plant-origin. Although both indexes did correlate modestly
with several relevant dietary change variables, we can’t draw conclusions about these
correlations because all variables were derived from the same outcome measure (i.e. the FFQ).
However, both indexes also correlated modestly with changes in perceived dietary pattern, selfefficacy and motivation to eat a plant-based diet, and with weight changes. In general, the PDIT
appeared to have slightly stronger correlations, perhaps because it was the more conservative
measure of dietary change and did not exclude any food items.
Both indexes were affected by the strengths and weaknesses of the Block FFQ used in this study.
We selected this FFQ in part because it included several important plant-based items (such as
soy milk, tofu or meat-alternatives) that would not be captured by other FFQs. However, like
most FFQs, the Block FFQ contained items of mixed plant and animal origin as well as items
that could be prepared with or without animal-origin foods (e.g. pizza, Chinese food, etc.). We
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were forced to label these items as “other” and excluded them in the PDI and only included them
in the denominator of the PDIT. At baseline, these “other” items accounted for almost 40% of
reported calories in our participants. Thus, we would expect that such a large “other” category
would limit our ability to detect a shift to a plant-based diet by these indexes. This problem could
be easily avoidable in future research by employing a food-dairy method of measuring dietary
change or by modifying the FFQ accordingly.
Another weakness of these indexes is their limited ability to distinguish between high and low
quality plant-based foods, as the indexes are only a measure of caloric contribution. This is
important because many (if not most) healthy plant-based foods are of very low caloric content
(e.g. fruits and vegetables) and many unhealthy plant-based foods are of high caloric content
(e.g. French fries, refined carbohydrates, etc.). We were able to minimize this problem by the
creation of the “other” category, which contained the majority of the “more unhealthy” plantbased items. Although the goal might be to eventually limit the contribution of the “other”
category in future indexes as discussed above, the nature of this phenomenon must be accounted
for somehow. Perhaps the solution will be to delineate sub-categories within the “plant” category
that reflect dietary quality.
In this study, our novel indexes correlated well with an objective measure of clinical
improvement, i.e. weight change. Future research is needed to further elucidate the value of these
indexes and their ability to predict outcome.
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Improvements in weight management?
This pilot study was successful at demonstrating modest and progressive short-term weight loss.
By 9 months post baseline, intervention participants had lost 5.5% of their initial body weight
(8.8 lbs) on average. As discussed, this observation is limited by our small control period (during
which participants gained an average of almost 3 lbs in 4.3 weeks). Thus whether the weight
change observed in intervention participants was due to our intervention or to some other
unknown factors can not be known with certainty. However, we did not observe increases in
activity that could account for the weight loss. In fact, if anything, activity decreased during the
study period. We retained about 70% of our participants until the end of the study, but loss of
participants may have influenced our results. Including dropouts in our intention to treat analysis
did not significantly change our outcome (7.8 lbs vs. 8.8 lbs at 9 months), but we can not know
how outcomes would have changes were we able to retain 100% of participants. We also
attempted to adjust for several socio-demographic variables, none of which appeared to make
major contributions to the observed weight change. With no intervention we would expect these
participants to gain weight over time (as occurs in the general population). Thus, we feel
modestly confident that our intervention aided weight management efforts in our participants.
In addition, our study of body composition changes on the subset of participants that fit on our
DEXA scanner revealed consistent findings (a mean of 12.8 lbs weight loss at 9 months with
roughly equal loss of lean and fat mass). The loss of lean mass in addition to fat mass is not too
surprising but is notable. That said, we can not be sure what proportion of the “lean” mass
included loss of peri-visceral fat or intramuscular fat.
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At different timepoints, weight loss correlated modestly with a decrease in dietary cholesterol, an
increase in percent carbohydrates, an increase in fruits and vegetable servings, a decrease in meat
servings and calories from animals, increases in plant-based indexes and the recommended food
score and a decrease in the Vegan-Omnivore Scale (i.e. movement towards vegan). These
observations are consistent with findings in the literature that suggest a plant-based diet improves
weight management.179, 182
What is intriguing about our pilot was that we did not observe a peak in weight loss. This
suggests that our participants achieved a small but significant caloric deficit that was maintained
throughout the study. This is exciting because our goal was to facilitate the adoption of a
sustainable dietary pattern conducive of improved long-term weight management.
As with dietary change, we expect that a more intensive intervention would have produced more
dramatic results. However, we specifically elected to study dietary change and not
comprehensive lifestyle modification. How this intervention would contribute to a
comprehensive lifestyle modification program for weight loss or maintenance is not known, but
certainly worthy of study. Unfortunately, this study did not afford the opportunity to compare our
intervention with other available treatment approaches.

Blood Pressure, Lipids and Glycemic Control
This study was not designed to detect statistically significant changes in the physiologic
outcomes measured. Still by the 9 month point we observed changes in weight that should be
sufficient to induce changes in physiology in some patients. (Generally, 5-15% loss of initial
body weight is required, we observed 5.5%).
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Average blood pressure dropped in both control and intervention periods. However, significant
within group change was only observed in the intervention group at 3 months (both systolic and
diastolic, -8.7 and -5.9 mmHg) and at 9 months (systolic only, -7.5 mmHg). Between group
changes were not statistically significant, likely because blood pressure exhibits large degrees of
within person variability and out sample size was small.
Blood draws were not done in the control group and thus only within intervention group changes
were observable. We observed progressive decreases in total cholesterol and LDL cholesterol at
3 and 9 months, but these were not statistically significant. Reductions in HDL were also
observed at both timepoints and these were statistically significant. A short-term reduction in
HDL is often observed in patients who increase carbohydrate intake (e.g. those who move
towards a plant-based diet). The significance of this is a topic of great debate. In studies of
patients with severe coronary disease, shifting to an almost exclusive plant-based diet was
associated with a transient reduction in HDL but improved clinical outcomes both in the short
term and in the long term.135 The explanation offered for this observation is that the reduction in
HDL does not reflect a decreased ability to remove cholesterol from the body (as it likely does in
epidemiological studies that have strongly associated low HDL levels with risk of heart disease)
but rather reflects a decreased need to excrete cholesterol (thanks to a change in dietary pattern).
Nonetheless, it was encouraging that total and LDL cholesterol continued to decrease over time
in our participants, whereas HDL decreased maximally at 3 months and thus the ratios of total
and LDL cholesterol to HDL cholesterol did not change significantly at 9 months.
Triglycerides did not change significantly at either 3 or 9 months although we saw wide variation
in triglyceride changes (SD=61 and 41 mg/dl at 3 and 9 months). Similar to HDL, triglycerides
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may worsen with increasing carbohydrate loads. For some of our participants prone to
hypertriglyceridemia these changes may have been clinically significant (although, the mean
baseline triglyceride was only 130 mg/dl, SD=54). This highlights the potential benefits of
incorporating individualized dietary and exercise counseling into a vegan healthy eating
program.
We observed decreases in fasting glucose at both 3 and 9 months in participants with impaired
fasting glucose at baseline, but these too were not statistically significant. Curiously,
glycosylated hemoglobin did change significantly in this subset except at 9 months (+0.55%).
These results are inconsistent with each other, but since glycosylated hemoglobin is a more
chronic measure of glycemic control it is likely the more representative of the two measures.
Assuming that glycemic control did worsen slightly at 9 months this may be accounted for
partially by the decrease in activity observed at 9 months (which was not observed at 3 months)
and was possibly compounded by an increase in carbohydrate load. Interestingly, at baseline our
participants reported consuming only 46% of calories from carbohydrates. This suggests that our
participants were consciously or unconsciously restricting carbohydrate intake, which may be a
common reaction to worsening insulin resistance (which often accompanies worsening obesity).
In this context, a worsening of glycosylated hemoglobin should not be interpreted as a worsening
of insulin resistance or diabetes but rather as an unmasking of insulin resistance.

Other limitations
The three main limitations to this study have already been discussed – the small sample size, the
lack of a long-term control group, and the use of food frequency questionnaires to measure
dietary change. Other limitations include our inability to accurately distinguish between the
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contributions of the various intervention components (e.g. the health and nutrition education vs.
the group support inherent to group interventions vs. the environmental and animal ethics
education, etc.). The degree of randomization was also a limitation to our between group
analysis. Although we did randomize participants who could attend either a Wednesday or
Monday group to one or the other, this only constituted 6 of the 29 participants enrolled.
Nonetheless a comparison of control vs. intervention groups did not reveal any significant
differences in socio-demographic, weight and selected behavioral and dietary variables. Finally,
the short length of this study is also a major limitation.

The use of non-traditional motivators for dietary change
Social marketing tactics to curb behavior have been widely utilized in public smoking cessation
campaigns but much more rarely in dietary change efforts. Yet the potential use of motivators
other than a concern for health in a manner analogous to social marketing warrants exploration
given the widely held understanding that dietary choices are shaped by numerous factors beyond
a concern for personal health. This pilot trial was the first study we know of to utilize a range of
“vegan motivators” to influence dietary choices in an obese population. As discussed above, the
feasibility of employing such an approach, the satisfaction with the approach reported by our
participants, and the outcomes achieved supports the inclusion of such motivational tactics in
future research trials.
Beyond the implications this study has on future research are its implications on the nature of
dietary discussions. For it is perhaps remiss to discuss diet from a clinical or public health
perspective without acknowledging the larger implications of dietary recommendations.
Population wide dietary patterns have substantial influence on (and in turn, are influenced by)
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agricultural and food-related industries – two of the world’s largest industries. Collectively, these
industries have a dramatic impact not only on public health but also on the health of our global
environment and our economy. The interactions between diet, agriculture, the environment,
public health, and the economy are understandably complex. Still, they are worthy of
consideration when offering dietary advice to the population at large. For example,
recommendations to consume large quantities of fish for cardiac protection should be tempered
with the recognition that the world’s oceans have been perilously over-fished. Likewise,
proponents of high animal protein diets (aka ‘low carb’ diets) should recognize the enormous
resource strain and pollution caused by widespread adoption of these dietary patterns. Given that
there are many dietary options available to western populations, these factors should be
considered in weighing the pros and cons of each pattern. Furthermore, it can be argued that
clinicians, researchers and public health advocates have a responsibility to develop and advocate
dietary health promotion and disease prevention strategies that benefit not only human health but
the larger world we depend upon.

The use of vegan diets in clinical settings
This study did not aim to place participants on a vegan diet. However, the benefits of a vegan
dietary pattern were emphasized throughout the intervention and a number of our participants
elected to adopt a vegan or near vegan dietary pattern. There are important limitations to the use
of vegan diets for both short and long-term dietary interventions, however these limitations are
often poorly understood in both the scientific and lay communities. The largest perceived
limitations are nutritional adequacy, supplementation, social stigma, costs, and the reality of the
current nutritional environment.
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Fears of vegan diets being nutritionally inadequate are often over-blown. It is the joint position
of both the American and Canadian Dietetic Associations that vegan diets can be nutritionally
adequate.67 Even low-fat, vegan diets used in long-term clinical trials have been shown to be
nutritionally adequate.183,

184

However, it is true that planning both an “adequate” and an

“optimal” vegan diet requires both skill and attention and benefits from the use of supplemented
foods (see below), but the same must be said for non-vegetarian diets. Of course, a vegan diet, in
the most general sense of this term, is not guaranteed to be nutritionally adequate, as discussed in
the background section. This may be especially true for people who adopt a vegan diet for nonhealth based reasons. Thus, it is probable that clinically applied vegan diets are more often
nutritionally adequate than freely adopted vegan diets; although, this is a matter worthy of
scientific study.
Vegan diets, in the modern nutritional environment, should be supplemented for certain
micronutrients, especially vitamin B12. Some individuals eating a vegan diet would also benefit
from individualized dietary counseling and/or supplementation with iron, zinc, vitamin D,
calcium and essential fatty acids.67, 185 Fortunately, a multi-vitamin/mineral supplement and/or
fortified soy or rice drinks can be utilized with relative ease to meet these needs. Given that most
vegetarians meet or exceed the RDA for protein, there is no general indication for protein
supplementation. Similarly, protein-combining at each meal in unnecessary.67 Finally, in both
vegan and non-vegetarians alike there is potential for insufficient and excess caloric intake, and
care should be taken to avoid either of these extremes.
Contrary to popular perception, vegan diets are not inherently more expensive than non-vegan
diets. In fact, the reason why the majority of the world’s population subsists mainly on foods of
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plant origin is because of cost. However, fast, convenient or ready-made vegan foods may in fact
be more expensive than non-vegan options (e.g. McDonalds).
Labeling a dietary pattern with a name tends to bring on stigmatization and social isolation.
Historically, some self-defined “vegetarians” and “vegans” in Western populations experienced
significant degrees of social isolation.154 This probably remains true today, but to a lesser degree.
In general, stigmatization and social isolation are associated with poorer health outcomes.
Whether these social forces have a significant impact on vegetarian populations is an intriguing
question that has not been well studied. Fortunately, trends indicate that “vegetarianism” is
slowly gaining popularity,67 and this may lead to less stigmatization and social isolation.
The fact that vegan options are not as accessible as non-vegan options in the current nutritional
environment is both an advantage and disadvantage. For example, having less food available
could be theorized to decrease caloric intake, which given the current obesity epidemic would be
advantageous.

On the flip side, decreased food availability might make a vegan diet less

sustainable for a variety of reasons. However, it should be argued that decreased access to some
vegan options (such as fresh fruits and vegetables) is a major disadvantage for both vegans and
non-vegans alike. It is also important to note that access to vegan food options has been
increasing steadily over the past few decades because of increased demand.67 Importantly,
advocating a plant-based or vegan diet should also have the effect of increasing demand and thus
increasing access to plant-based foods.
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Future directions
Like most research, this pilot study has raised more questions than it set out to answer. Several
potential directions for future research have been alluded to in the above discussion. For
example, it would be interesting and worthwhile to assess the impact of a vegan healthy eating
program on the maintenance of dietary change and weight loss as achieved by a more intense
dietary change or comprehensive lifestyle modification program. In addition, methods to
enhance the impact of this type of dietary education (e.g. behavioral psychological techniques)
may be worth exploring. Whether this type of education is more effective in individual vs. group
vs. a combined setting should be studied, as should the impact of this approach compared to
more standard means of dietary counseling. Above all, a long-term randomized controlled
trial is warranted to explore the impact of using motivators beyond health on our ultimate
goal: the long-term maintenance of healthy dietary change and weight loss for the
prevention and treatment of obesity.
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UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
CONSENT TO BE A RESEARCH SUBJECT
The Pilot Trial of the Vegan Healthy Eating Program for Obese Adults
A.

PURPOSE AND BACKGROUND

Mark Berman from Yale University School of Medicine and a Doris Duke Clinical Research
Fellow at UCSF, Robert Baron, MD, from the Department of Medicine and the Principal
Investigator of this study, Ruth Marlin, MD from the Preventive Medicine Research Institute
(PMRI), and Dean Ornish, MD, from the Department of Medicine and PMRI are conducting a
study to learn whether an experimental educational program can help obese individuals eat a
healthy vegan diet that will maintain their recent weight loss or cause them to lose weight. A
vegan diet is based on vegetables, fruits, grains, beans and other legumes, nuts, and seeds and
does not contain foods made from animals (e.g. milk, red meat, chicken, fish, etc.).
This study is being funded in part by the Doris Duke Charitable Foundation and by the General
Clinical Research Center (GCRC) at UCSF.
You are being asked to participate in this study because you are obese and are interested in
maintaining your current weight loss or loosing additional weight.
B.

PROCEDURES

If you agree to be in this study, the following will happen:
1. You will be asked whether you are able to join the Monday or the Wednesday group.
Both groups meet at the same time and place, but one only on Mondays, the other
only on Wednesdays. One of these groups will begin 4-6 weeks after the other. If you
can only attend Monday or only Wednesday, you will be placed in that group if there
is still room in it. If you can attend either group, your placement into one of the
groups will be assigned by a computer (i.e. by chance).
2. You will be asked to fill out a number of questionnaire forms about your current
health and your eating habits. Then your weight, height, waist, hip and blood pressure
will be measured. This should take 70 to 100 minutes.
3. You will be asked to return to the GCRC after fasting overnight to have a small
amount of blood (approximately 2 tablespoons) collected. This blood will be analyzed
to look at your cholesterol and lipid values and blood sugar. The blood draw should
take about 5 minutes.
4. After the blood draw your body composition will be analyzed to determine how much
muscle, fat and bone you have. This will be done using a dual energy X-Ray
absorptiometry (DEXA) scan. The DEXA scan will give information about the
amount of muscle, fat and bone in your body. For this measurement, you will lie on
your back on a table and be scanned from head to toe by a machine that measures the
absorption of X-Ray energy through your body. This should take 15-20 minutes. If
you are a female of child-bearing age you will be required to have a pregnancy test
Appendix – Consent Form
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performed prior to the DEXA scan. This involves collection of a urine sample. If the
pregnancy test is positive, the DEXA scan will not be done.
5. After the DEXA Scan you will be given an Activity Monitor to wear for 4 days. This
is a little box about the size of a pager that measures movement. This will give us an
idea of how much daily activity you do.
6. You will be notified by phone of the exact starting date of the educational program.
7. If you are in the second group, you may be asked to return to the GCRC to fill out the
food questionnaires and repeat the body measurements (height, weight, waist, hip,
blood pressure). This should take 70-100 minutes.
8. The first and main part of the educational program will be held once a week for 6
weeks, starting at 6pm on either Monday or Wednesday. Each session will last 2.5 to
3 hours and about 30 minutes of ‘homework’ will be assigned each week. The course
will be held at the General Clinical Research Center (address below).
9. Each session will have several parts: Most sessions will begin with a “group checkin” where every participant will be asked to share their recent experiences or thoughts
about their current diet. One or two lectures or videos will be presented followed by a
question, answer and discussion period. The topics of each session are included on a
separate paper, please review them and ask any questions now. The fifth session will
include a video about animal farming which contains some graphic material about
how cows, chickens and pigs are raised for food. This material is representative of
current factory farming conditions. At the end of the session you will be asked to fill
out a short survey to tell us your thoughts about that particular session. The survey
should take 5 to 10 minutes maximum. Some of the lectures given during the sessions
may be videotaped for the purposes of improving future courses or providing makeup sessions. However, the video recorder will be set up so that none of the
participants will be videotaped.
10. If for some reason you miss a session, we will try to provide you with alternative
materials that cover the same topic as the session. This may involve reading or
watching one or more videos.
11. Within 1 to 2 weeks of ending the 6th session you will be asked to return to the GCRC
to repeat the questionnaires, body measurements, and blood pressure.
12. The second part of the education program will begin within 1 to 2 weeks of the last
session (i.e. the 6th session) and will run on the same day (i.e. Monday or Wednesday)
but for only 1.5 - 2 hours and only every 2nd week for 3 sessions. These sessions will
be designed to help you maintain any dietary change that occurs during the first part
of the program. The content of the sessions will be similar but will be focused more
on practical aspects of food preparation, eating and shopping. The content will be
designed based on the feedback and desires of each group.
13. At the end of the study period (3 months from the start of the course) you will be
asked to return to the GCRC one last time to repeat the questionnaires, body
measurements, blood test, DEXA Scan and Activity Monitor.
Participation in the study will take a maximum of 3.5 hours per week for 6 weeks, then a
maximum of 2 hours every second week for another 6 weeks. There will also be 3 (or 4) separate
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sessions for the questionnaires and blood draw which will last about 1.5 - 2 hours. In total, this is
a minimum of about 27 hours and maximum of 35 hours over a period of 3 months.
All study procedures will be done at The General Clinical Research Center at U.C. San
Francisco, 505 Parnassus Avenue, Room M-1296, San Francisco, California 94143. Telephone:
415-476-6148.
C.

RISKS/DISCOMFORTS

The following risks/discomforts may occur if you participate in this study:
a) Some of the videotapes that will be shown in the educational sessions (mostly in session
5) are likely to produce unpleasant or strong feelings as they will contain some graphic
material representative of current factory farming conditions (e.g. animals confined in
tight quarters, animal handling practices that occur in the US, including animals being
hit by frustrated workers, and the dragging of lame animals; as well as the transport,
auction, living and slaughter conditions of factory farmed animals.), but you will be able
to stop watching at any time, if you feel too uncomfortable. Similarly, some of the group
discussion questions (e.g. what was your reaction to the information you just learned?)
may make you uncomfortable or upset, but you are free to decline to answer any
questions you do not wish to answer or to leave the group at any time.
b) Confidentiality: Participation in research will involve a loss of privacy; however, your
records will be handled as confidentially as possible. The researchers will ask you and
the other people in the intervention group to use only first names during the group
session. They will also ask group members not to tell anyone outside the group what
any particular person said in the group. However, the researchers cannot guarantee that
everyone will keep the discussions private. No individual identities will be used in any
reports or publications that may result from this study.
c) Venipuncture (Blood draw): The risks of drawing blood include temporary discomfort
from the needle stick and bruising, and rarely, infection.
d) Vitamin B12: if you choose to adopt a completely vegan diet, you may have inadequate
Vitamin B12 intake. While a B12 deficiency would likely take many months or years to
develop and would not manifest during this study, this is an important and easily
avoidable risk. Taking a multivitamin or using supplemented foods (e.g. fortified soy or
rice milk, cereals, etc.) is an easy way to avoid this risk.
e) You may find participating in this study and the need to have testing and fill out
questionnaires burdensome, frustrating or boring.
.
f) Duel Energy X-Ray Absorptiometry (DEXA) Scan: The amount of X-Ray you will be
exposed to is less than .05 mrem, which is significantly less (about 1/4) than a single
chest X-Ray.
g) Activity Monitor: There is no risk associated with using the activity monitor.
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Treatment and Compensation for Injury:
If you are injured as a result of being in this study, treatment will be available. The costs of such
treatment may be covered by the University of California depending on a number of factors. The
University and the study sponsor do not normally provide any other form of compensation for
injury. For further information about this, you may call the office of the Committee on Human
Research at (415) 476-1814.
D.

BENEFITS

The potential benefit to you is that the educational program you receive may help you adopt a
healthier dietary pattern and achieve weight loss or maintain weight loss, although this cannot be
guaranteed.
Alternatively, you may receive no direct benefit from participating in this study. However, it is
hoped that the information gained from the study will help the researchers learn more about how
to improve people’s ability to maintain a healthy diet and/or weight loss.
E.

ALTERNATIVES

If you choose not to participate in this study, you could choose to receive no treatment for weight
management or you could participate in any treatments aimed at maintaining weight loss without
having to undergo the tests and education program involved in the study. These treatments
include dietary counseling, group support sessions, very low calorie diets, exercise counseling,
prescription drugs, bariatric surgery and commercial weight loss programs. With the exception of
very low calorie diets, prescription drugs, surgery and commercial weight loss programs, you
will still be free to participate in these other treatments while participating in this study.
Information about vegan diets and their effect on health and the environment is available to the
public in other forums.
F.

COSTS

There is no cost for participating in this study.
G.

PAYMENT

You will be paid a maximum of $60 for your participation in this study, $15 for each time you
complete a set of questionnaires and a blood draw. You will be paid in cash immediately after
you complete the set of questionnaires and blood draw. Your parking fees or public
transportation fees for attending the sessions and completing the questionnaires and blood draw
will also be reimbursed at the end of each session.
H.

QUESTIONS

This study has been explained to you by Mark Berman, Dr. Robert Baron or Dr. Ruth Marlin or
the person who signed below and your questions were answered. If you have any other questions
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about the study, you may call Mark Berman at (415) 332-2525 extension 290 or Ruth Marlin at
(415) 332-2525 extension 228, or Robert Baron at (415) 476-0438.
If you have any comments or concerns about participation in this study, you should first talk with
the researchers. If for some reason you do not wish to do this, you may contact the Committee
on Human Research, which is concerned with the protection of volunteers in research projects.
You may reach the committee office between 8:00 and 5:00, Monday through Friday, by calling
(415) 476-1814, or by writing: Committee on Human Research, Box 0962, University of
California, San Francisco/San Francisco, CA 94143.
I.

CONSENT

PARTICIPATION IN RESEARCH IS VOLUNTARY. You have the right to decline to
participate or to withdraw at any point in this study without jeopardy to your medical care at
UCSF.
If you wish to participate, you should sign below.
_______________________
Date

___________________________________________________
Subject’s Signature

___________________
Date

___________________________________________
Person Obtaining Consent
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Appendix Figure 1. Designation of Plant, Animal or Other Category for Block 98.2 FFQ Items
Plant

Animal

Other

Tomato juice, V- juice
Orange juice, grapefruit juice
Real fruit juice excl. orange, grapefruit.
Drinks w. some juice, Sunny D
Peaches, apricots, fresh, seas
Cantaloupe in season
Strawberries in season
Watermelon in season
Other fruits in season
Bananas
Apples or pears
Oranges, tangerines
Grapefruit
Canned fruit, applesauce, etc
Cooked cereal or grits
High fiber cereals
Cold Cereal (Total, Just Right, etc.)
Cereal excl. fiber or fortified
Broccoli
Carrots
Corn, fresh, frozen or canned
Green beans or peas
Spinach (cooked
Greens like collards
White potatoes baked, mashed
Sweet potatoes
Green salad
Raw tomatoes
Other vegetables
Refried beans, bean burritos
Baked beans, black-eye peas, pintos
Vegetable stew
Lentil, pea or bean soup
Pasta salad, other pasta dish
Tofu, bean curd
Meat substitutes (not just soy)
Peanuts, other nuts & seeds
Dark bread, whole wheat, rye
White bread, French, Italian, etc.
Rice or dishes with rice
Tortillas - Corn or flour
Peanut butter
Salsa, ketchup, taco sauce

Cooking Fat - Butter
Cooking Fat – Lard
Reduced fat % Milk
Cream in coffee
Cream/milk in tea
Eggs or egg biscuits
Bacon
Breakfast sausage
Yogurt, frozen yogurt
Cheese and cheese spreads
Cheese dish like macaroni/cheese
Hamburger, cheeseburger
Tacos or burritos*
Beef (roast, steak, sandwiches
Pork chops, roasts, dinner ham
Veal, lamb or deer meat
Ribs, spareribs
Liver, liverwurst
Gizzard, neckbones, chitlins
Mixed dishes with beef or pork
Mixed dishes with chicken
Fried chicken
Chicken not fried
Oysters
Shellfish (shrimp, crab, etc.)
Tuna casserole, tuna sandwich
Fried fish
Fish not fried
Hot dogs or dinner sausage
Ham, boloney, lunch meats
Ice cream
Butter

Cooking Fat - PAM OR NO OIL
Cooking Fat - Stick margarine
Cooking Fat - Soft margarine
Cooking Fat - Half margarine, half butter
Cooking Fat - Diet margarine
Cooking Fat - Vegetable oil
Cooking Fat - Olive oil, canola oil
Cooking Fat – Crisco
KoolAid, Hi-C,Vit.C-rich drinks
Soft drinks or Snapple not diet
Breakfast or diet shakes, Ensure
Beer (regular)
Wine or wine coolers
Liquor or mixed drinks
Coffee
Tea or iced tea (not herb tea)
Pancakes, waffles, Pop Tarts, French toast
Breakfast bars, Power bars, granola bars
Salad dressing
Chili with beans (with or without meat)
French fries, fried potatoes
Coleslaw, Cabbage†
Vegetable-beef/chicken soup, etc.*
Other soups (Chicken noodle, chowder, etc.)*
Spaghetti, lasagna, pasta w. tomato sauce*
Pizza
Chinese dishes
Salty snacks (chips, popcorn)
Crackers
Doughnuts, pastry
Cake – regular
Cookies, regular
Pumpkin pie, sweet potato pie
Pie or cobbler
Chocolate candy, candy bars
Candy (not chocolate)
Biscuits, muffins
Bagels, English muffins, buns, rolls
Cornbread or hush puppies, corn muffins
Margarine
Gravy
Jelly, jam, syrup
Mayonnaise, sandwich spreads
Mustard, BBQ sauce, other sauce

*note: analysis uses items with meat & dairy
†note: analysis includes mayo
Block 98.2 FFQ & Block Food Portion Diagram available from Berkeley Nutrition Services www.nutritionquest.com
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The Vegan Healthy Eating Program - SURVEY

A BIT ABOUT YOU:
Please complete the following information to tell us a little bit about you. The information collected
from this page will help us to tell how the participants in our study compare to other patients seen at
UCSF clinics or the broader US population. It will also help us determine whether some groups of
individuals do better than others in this program. We recognize that many of the questions are very
personal, and we will ensure that your responses are kept confidential. Only the study directors and
their research assistants will view these forms. Please leave blank any questions that you are
uncomfortable answering.

1. What is your highest level of education?
finished Grade School or
less

some High School

High School Diploma
or equivalent (GED)

Associate Degree

Bachelor’s Degree

some Grad School

some College

Master’s or Doctorate Degree

2. Are you currently single, married or living with a partner?
I am single or living alone

I am married or live with my partner

3. What is your current employment status?
I work full time
(40 hours of more per week)

I work part time
(20-39 hours per week)

I work less than part time
(less than 20 hours per week)

I am unemployed (seeking employment)

Not seeking employment (e.g. retired, homemaker, etc.)

4. What is your approximate yearly combined household income?
0 – $10,000

$11,000 – $20,000

$21,000 – $30,000

$51,000 – $70,000

$71,000 – $90,000

$91,000 or more

5. Do you currently have medical insurance?
Yes

No
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PART A: Your Current Diet:
The next 3 pages ask you about your current eating habits and how confident
you are that you could change your diet, if you wanted to.
NOTE: It is very important that you answer these and all questions on this survey to
best reflect how you feel right now. Although some people may have strong opinions
about these issues, this should not influence your responses. The quality of this
research depends on your honesty. Please try to answer all questions but feel free to
leave blank any questions that you are uncomfortable answering. Thank you!

1. Please pick the ‘diet style’ that best reflects what you currently eat:
omnivore (e.g., a person who eats most animal, seafood, and fish products in addition to
vegetables, fruits, and grains),
dairy and fish vegetarian (e.g., a person who eats vegetables, fruits, grains, dairy products,
eggs, seafood, and fish but no white or red meat),
lacto-ovo vegetarian (e.g., a person who eats vegetables, fruits, grains, dairy products, and
eggs but no seafood, fish, white meat, or red meat),
vegan (e.g., a person who eats absolutely no animal products including dairy products,
eggs, seafood, fish, white meat, and red meat)

2. Please circle the number that best reflects what your current diet is like:
1
Vegan

2

3

4

5

6

7

8
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10
Omnivore
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3. Please fill in the circle the best answer to this question:
“Are you currently eating a plant-based diet (a diet that is mostly made of grains, vegetables, fruit, beans and
legumes, nuts and seeds, and includes very little or no foods made from animals, e.g. milk, meats, eggs, cheese,
fish, etc.)?”
YES (please skip question 4)

If you picked any of these 3
options, please go to question 4.

NO, I have never eaten this type of diet
NO, I used to, but recently stopped temporarily
NO, I have tried one or more times, and have given up

4. Are you ready to start eating a plant-based diet now?
YES
NO

Please answer each question below by circling a number on the scale underneath
each question.

If it were recommended that you do any of the following, starting right now, how
confident would you be that you could:
5.

Eat less animal products (e.g. cheese, meat, eggs, butter) both at home and
outside your home?

1

2

3

4

5

6

Not at all confident

7
Very Confident

Feel free to explain why: ______________________________________________
___________________________________________________________________

6.

Eat more whole-grains (e.g. brown rice, whole wheat bread, oatmeal) both at home
and outside your home?

1

2

3

4

5

6

Not at all confident

7
Very Confident

Feel free to explain why: ______________________________________________
___________________________________________________________________
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Please answer each question below by circling a number on the scale underneath
each question.

If it were recommended that you do any of the following, starting right now, how
confident would you be that you could:
7.

Eat less refined, processed or fast foods (e.g. white bread, white rice, margarine,
French fries, oils, candy, etc.)?

1

2

3

4

5

6

Not at all confident

7
Very Confident

Feel free to explain why: ______________________________________________
___________________________________________________________________

8.

Shop for and prepare meals that do not include animal products?

1

2

3

4

5

6

Not at all confident

7
Very Confident

Feel free to explain why: ______________________________________________
___________________________________________________________________

9.

Eat a vegan diet despite the challenges this may pose?

1

2

3

4

5

6

Not at all confident

7
Very Confident

Feel free to explain why: ______________________________________________
___________________________________________________________________

10. Take a daily multivitamin containing vitamin B12?

1

2

3

4

5

6

Not at all confident

7
Very Confident

Feel free to explain why: ______________________________________________
___________________________________________________________________

The next section asks about your thoughts on eating a plant-based diet…
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PART B: A Plant-Based or Vegan Diet
The next 3 pages ask about your thoughts on eating a plant-based or vegan diet.

List all the advantages and disadvantages that are important to you for
decreasing the amount of foods, drinks or meals you eat that are made from
animal products (e.g. milk, meat, cheese, eggs, etc.) and for increasing the
amounts of food, drinks or meals you eat that are made from plant products
(e.g. fruits, veggies, tofu, brown rice, etc.):

DECREASE THE AMOUNT OF ANIMAL-PRODUCTS

INCREASE THE AMOUNT OF PLANT-PRODUCTS

(beef and other meats, milk, eggs, etc.)

(Fruits, Vegetables, Beans/Soy, Whole Grains, etc.)

Advantages

Advantages

Disadvantages

Disadvantages
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A plant-based diet is a diet made of grains, vegetables, fruit, beans and legumes,
nuts and seeds, and includes very little or no foods made from animals, e.g. milk,
meats, eggs, cheese, fish, etc.

Please circle the number that best answers each question below:
1. How motivated are you to eat a plant-based diet?
1

2

3

4

5

6

7

Not motivated at all

Extremely Motivated

2. How difficult is it for you to eat a plant-based diet?
1

2

3

4

5

6

7

Not difficult at all

Extremely Difficult

State how much you agree with the following statements by circling a number
next to each statement:
Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree

3. “I plan to eat a plant-based diet
for the next month”

1

2

3

4

5

4. “I plan to eat a plant-based diet
for the next year”

1

2

3

4

5

5. “In the future, I plan to eat a
plant-based diet most or all of
the time.”

1

2

3

4

5

You Are HALF-WAY done!
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Participant Name: _________________ Participant ID: ____ Date:___________

PART C: Your Opinion about Food, Animals & the Environment
The following questions ask for your opinion. There are no right or wrong answers to
these questions. Please select the answer you most agree with.
Please read each statement below VERY carefully. State how much you agree with
the following statements by circling a number next to each statement:
Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree

1. “Eating a vegan diet would not improve my
health.”

1

2

3

4

5

2. “Eating a vegan diet would make it easier for
me to maintain a healthy weight.”

1

2

3

4

5

3. “I consider myself an animal lover.”

1

2

3

4

5

4. “I do not consider myself an
environmentalist.”

1

2

3

4

5

5. “I know more about the treatment of farm
animals than most people my age.”

1

2

3

4

5

6. “I am not concerned about how farm animals
are raised for food.”

1

2

3

4

5

7. “Because of what I know about how animals
are raised for food, I eat less meat and other
animal products.”

1

2

3

4

5

8. “I am concerned about the state of the
environment.”

1

2

3

4

5

9. “I know less about the state of the
environment than most people my age.”

1

2

3

4

5

10. “I am concerned about the impact of raising
animals for food on the environment.”

1

2

3

4

5

11. “Because of what I know about the impact of
raising animals for food on the environment I
eat less meat and other animal products.”

1

2

3

4

5

12. “I know more about the fast food industry
(working conditions, food safety, healthiness
of fast foods, advertising practices, etc.) than
most people my age.”

1

2

3

4

5

13. “I am not concerned about the nature of the
fast food industry or the foods sell.”

1

2

3

4

5

14. “Because of what I know about the fast food
industry, I eat more fast-food.”

1

2

3

4

5

Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree
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PART D: A Food Quiz
The following questions are about diet and health, obesity, the environment
and farming. Warning: THESE ARE VERY CHALLENGING QUESTIONS.
We have purposefully made these difficult to see if our educational course
has taught information that most people do not know. It is ok if you don’t
know the right answer to many or all of these questions, but try to guess the
answer that seems most reasonable to you.

Circle the best answer:
1.

Eating fruits and vegetables every day:
(A) Is not healthy, because it adds harmful sugar to my diet
(B) Helps protect against cancer and heart disease
(C) Should be limited because it adds too many calories to the diet
(D) Should be limited because fruits and vegetables may be sprayed with pesticides

2.

Eating meat and dairy every day:
(A) Is the only way to get enough protein and calcium in the diet
(B) Is necessary in order to be healthy
(C) Adds fat and cholesterol to the diet and is not needed for good health

3.

Losing a ‘modest’ amount of weight (e.g. 10-20 pounds) and maintaining that weight loss:
(A) Can significantly lower blood pressure, cholesterol and prevent the development of
diabetes
(B) Will not make me any healthier
(C) Can only be achieved by eating meat and cutting out breads, pastas and sugars.

4.

Most farm land in the US is used to:
(A) Grow fruits and vegetables for humans to eat
(B) Grow grains, cereals and legumes (beans) for animals to eat
(C) Grow grains to export to other countries
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Participant Name: _________________ Participant ID: ____ Date:___________
5.

103

Today, the leading cause of species “dying out” (becoming extinct) in the US and in the
Amazon rainforests is:
(A) Livestock (farm animals) grazing and growing food for animals
(B) Cutting down trees for housing, paper and firewood
(C) Natural disasters (hurricanes, floods, earthquakes, etc.)

6.

Which of the following is most true?:
(A) It is not important to conserve (save) water unless there is a drought.
(B) It is recommended that we conserve water at all times and eating less meat is one of
the most effective means to do this.
(C) It is recommended that we conserve water at all times and using less tap water (for
example, taking shorter showers, using less water when washing dishes or clothes,
etc.) is more effective than eating less meat.

7.

To make 1 gram of animal protein or 1 gram of plant protein requires the same amount
of energy:
TRUE
FALSE

8.

Most manure from farm animals in the US is re-used as natural fertilizer:
TRUE
FALSE

9.

The routine use of antibiotics in farm animals does not cause “antibiotic resistance” that
affects humans:
TRUE
FALSE

10.

Animal farming uses about four times less antibiotics than is used by humans (i.e. by
doctors):
TRUE
FALSE

11.

Animals are not fed to other animals in the US and the reason is because this may
increase the risk of transmitting diseases like Mad Cow Disease:
TRUE
FALSE
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Which of the following is most true?:
(A) About 90% or more of all animals raised for food in the U.S. are raised in “factory
farms” (i.e. not on small family farms).
(B) About 50% of all animals raised for food in the U.S. are raised in factory farms
(C) Less than 20% of all animals raised for food in the U.S. are raised in factory farms

13.

Every year, the number of animals killed for food in the US is about:
1. 1 million

(1,000,000)

2. 10 million (10,000,000)
3. 100 million (100,000,000)
4. 1 billion

(1,000,000,000)

5. 10 billion (10,000,000,000)
6. 100 billion (100,000,000,000)

Thank You Very Much
for completing the V.H.E.P. Survey!
Please take a minute to look over your answers and respond to any question you
may have skipped. If you have questions please feel free to ask them before you
turn this in!
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There are some words in the survey that you may not be familiar
with.
Here are some definitions that might be useful:
Animal products are foods that are made from animals. These include:
•
•
•
•

Meats -- beef, pork, chicken, turkey, etc.
Fish and Seafood
Dairy products -- milk, cheese, ice cream, butter, yogurt, etc.
Eggs

Some of these foods are contained in other foods (e.g. there is often eggs and
dairy in muffins and cakes).

Plant products are foods that are made from plants. These include:
•
•
•
•
•

Grains -- rice, wheat, oats, corn, etc.
Fruits -- apples, oranges, berries, bananas, melons, etc.
Vegetables -- broccoli, yams, lettuce, squash, cabbage, string beans, peppers,
etc.
Beans and Legumes -- chick peas, lentils, soy beans, tofu, split peas, kidney
beans, black beans, etc.
Nuts and Seeds -- peanuts, cashews, sesame seeds, walnuts, pumpkin seeds,
sunflower seeds, etc.

A Plant-Based diet is a diet made mostly of grains, vegetables, fruit, beans
and legumes (e.g. soy, tofu), nuts and seeds, and includes very little or no
foods made from animals (e.g. milk, meats, eggs, cheese, fish, etc.)

A Vegan diet is a type of plant-based diet that contains no foods made from
animals.
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Appendix Figure 2. MS Access Relational Database used for Data Entry and Export (for analysis)

Selected Abbreviations: NA, Nutrient Analysis; RFS, Recommended Food Score
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The Vegan Healthy Eating Program
Curriculum Overview
Session 1. Introduction – Overview of study, obesity and vegan nutrition
Part 1. Group check-in: introductions,
instructions for future check-ins

Mark,

Part 2. Overview of study and all sessions:
content and aims

Mark

Recap & Homework Overview

15 mins

PPT: intro to ecological nutrition concepts,
overview of sessions, speakers, study goals,
expectations, procedures…

20 mins
Definition; Risks – mortality, morbidity,
diabetes, cardiovascular diseases, arthritis,
cancers, etc.; psychosocial implications;
Benefits of modest weight loss; available
treatments for long-term weight loss
maintenance; questions.

Dr. Baron

40 mins

Stacey
DunnEmke

45 mins

Definition of vegan; brief summary of health
benefits of vegan diet; vegan food pyramid;
getting ‘enough’ protein; sample menu and
nutritional breakdown; tips for getting started;
overcoming expected pitfalls. Questions.

Mark

5 mins

Finish Vegan starter kit; Sample menu forms

Break
Part 4. Lecture: Basic Vegan Nutrition – vegan
food groups, sample meals

Distribute name tags; Person-by-person intro
(name, occupation/location, motivation for
participating in VHEP…)

Dr. Marlin

Dinner Break
Part 3. Discussion: Obesity – what is it and
why does it matter? Health
consequences of obesity and common
co-morbidities.

30 mins

10 mins

Total

2 hrs, 45 minutes

Materials and Notes: Vegan starter kits and recipe book given out upon enrolling. Example menus or recipes, a
vegan food pyramid, and food substitution guide will be given for take home.
Homework: read vegan starter kit if haven’t done so. Create a 2 day vegan menu and shopping list for yourself /
family. Participants can take out an item from the library if desired.
SESSION 1 GOALS:
Check – in: participants should understand the purpose of check-ins: to share experiences, get to know
other members of the group, support each other, learn from each other’s experiences, voice concerns and
fears, and brainstorm how to overcome them.
Study Overview: participants should leave the overview excited about the program and the opportunity to
learn. They should feel empowered to maximize their educational experience during the program, to
challenge what they are taught, and to contribute as much energy as possible to the program; they should
understand the nature of all sessions, including session 5 and the maintenance sessions.
Obesity Discussion: participants should understand the utility of understanding obesity as a chronic
imbalance between energy intake and expenditure. They should understand that genetics, the modern
nutritional environment and factors that contribute to a sedentary lifestyle are important contributors to
obesity, but that this only increases the importance of taking control of one’s food and activity choices.
Participants should be given a basic understanding of the biological basis for overeating and fat
accumulation, and the worsening epidemic of overweight and obesity, as a means for minimizing self-blame
and increasing understanding of their condition. Participants should also be reminded of the health, socioeconomic and psychological impacts of obesity, as a means of reinforcing the value of this program and
validating their struggles. Participants should understand the importance of maintaining modest weight loss
and setting reasonable, long-term goals.
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Basic Vegan Nutrition Lecture: Participants should understand the meaning of the terms vegetarian, lactoovo, and vegan. They should become aware of the breadth of health benefits that come from adopting a
whole-foods, plant-based diet (by citing examples of epidemiological and clinical research). They should be
given a basic model for understanding this phenomenon, e.g. the wide range of protective factors found in
whole plant foods, pathogenic components in animal and processed foods. They should come away with
knowledge of all the food groups needed to make a wholesome vegan diet, and the relative calorie densities
between animal and plant foods, etc. They should gain an appreciation for the extremely high prevalence of
animal products in commercial foods, so that they do not blame themselves for some inevitable exposure to
animal products. However, they should also appreciate the benefits of maximizing adherence to a low-fat,
whole foods, vegan dietary pattern. They should understand why it is important to take a vitamin B12
supplement (e.g. multivitamin with B12), to make use of fortified foods. The downside of overemphasizing
protein requirements should be very clear and other protein myths should be addressed (e.g. complete
protein). Tips for transitioning to a vegan diet and a simple meal plan should be presented, as a means of
demonstrating that eating a vegan diet can be achievable and satisfying.

Session 2. Your health – the health benefits of a vegan diet
Part 1. Group Check-in: Homework Review

Mark

10 mins

Thoughts on Meal Planning exercise

Part 2. Lecture: Health benefits of a low-fat,
whole foods, vegan diet – overview of
clinical and epidemiological evidence
with respect to obesity and related
chronic diseases.

Dr.
Ornish

50 mins

Overview of heart & prostate ca research
(including case-studies); summary of evidence on
diet and obesity; low-fat vs. high protein debate;
other health benefits of a low-fat, whole foods,
plant-based diet.

Part 3. Question, answer & discussion period

Dr.
Ornish

20 mins

Dinner Break
Part 4. Group Discussion: Challenges to eating
a healthy plant-based diet.

Recap & Homework Overview

20 mins
Mark,
Dr.
Marlin
Mark

Break & Homework Selection

30 mins

Facilitated group brainstorm on
challenges/barriers to eating healthy plant-based
foods and how to overcome them.

10 mins

Choose item from the resource library

20 mins
Total

2 hrs, 45 minutes

Materials and Notes: Lectures from Co-I (Dr. Ornish). Handouts include tips on: dealing with food cravings,
eating healthy but inexpensively, minimizing flatus, and experimenting with new plant-based foods.
Homework: ”Choose a book, video, audio-cd, pamphlet or practical assignment from library. Make list of new
vegan foods in each food group to add to your diet.”
SESSION 2 GOALS:
Health lecture: participants should understand the important contribution of diet to health promotion and
disease prevention. They should understand the dose-response effect of diet in reversing heart disease, and
slowing the progression of prostate cancer. Participants should be given an overview of recent dietary trends
and how they have contributed to the worsening obesity epidemic. In this context, they should come to
understand the advantages of a low-fat vs. a high-protein approach to weight loss and health promotion.
Participants should be inspired by hearing case-reports of previous research participants and gaining insight
into the speaker’s own journey.
Group Discussion: Participants will have an opportunity to express the obstacles they face in transitioning
to a vegan or plant-based diet. The goal of this check-in is to validate the participants’ unique experiences
while providing a means for individual participants to benefit from the collective knowledge and experience
of the group. Participants should leave feeling their challenges are real but can be overcome by exercising
creative problem-solving, persistence and patience.
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Session 3. Your health & much more – an overview of how diet affects the environment,
farming practices, personal and public health
Part 1. Group Check-in: Homework Review

Mark

20 mins

Thoughts on resource-library item review.

Part 2. Lecture: The power of personal food
choices.

John
Robbins

45 mins

How the standard American diet contributes to
environmental destruction (in the US and
globally), chronic disease (including obesity)
and inhumane conditions for farm animals. An
emphasis will be placed on the significance of
personal dietary pattern and the
interconnection between all these issues.

Part 3. Question, answer & discussion period

John
Robbins

25 mins

Dinner & Break
Part 4. Group Discussion & Decision Balance
exercise
Recap & Homework Overview

30 mins
Mark,

35 mins

Group brainstorm on pros & cons of increasing
proportion of plant-foods.

10 mins

instructions for revising decision balance

Dr. Marlin
Mark
Total

2 hrs, 45 minutes

Materials and Notes: Lecture given by John Robbins – author of Diet for a New America and The Food
Revolution. Handouts include local vegan-friendly restaurants, tips for eating out and a ‘meal card’ for
restaurants/chefs.
Homework: “Revise vegan decision balance form.”
SESSION 3 GOALS:
Food-choices lecture: By tracing the origin of the food we eat back to the modern farm, participants should
become more aware of the interconnection between health, environmental and ethical food-production
issues. Thus, they will learn that their individual food choices have widespread implications beyond their
personal health. Participants will hear briefly about the living conditions of animals existing on most modern
factory farms and will gain insight into the scale of production needed to meet current consumer demand; as
a result, they will become aware of the role that consumer pressure plays in necessitating intensive
confinement farming. In a similar way, the link between animal agriculture, which is inherently inefficient, and
environmental pollution will also be explored. By demonstrating the strong links between these 3 issues,
participants should be empowered with the knowledge that small changes in their daily lives can have
widespread and meaningful implications. Participants will also be inspired by the author’s own tale of
personal transformation as well as by his vision of the power of personal food choices.
Group Discussion: By using a decision-balance format to discuss the pros and cons of both changing
dietary pattern and not changing (i.e. maintaining current) dietary pattern, participants will have an
opportunity to examine the relative weight of the perceived pros vs. the cons. In doing so, the goal is to
discuss the means by which participants can minimize the cons while maximizing the pros, such that the
decision to change is made consciously and independently despite known barriers.
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Session 4. Ecology – the environmental impact of animal-based agriculture
Part 1. Group check-in:

Mark,
Dr.
Marlin
Break

25 mins

10 mins

Part 2. Lecture: Food Choices for a Healthy
Planet

Dr.
Riebel

40 mins

Part 3. Question, answer & discussion period

Dr.
Riebel

20 mins

Dinner Break
Part 4. Lecture: Optimizing vegan nutrition

Recap & Homework Overview

early experiences, questions& concerns,
homework review

The inefficiency of animal-based agriculture and
the environmental consequences that result from
massive consumer demand; how a meat-based
diet contributes to substantial water, land and
energy strains, both locally and globally; the
impact of this resource strain and agricultural
pollution on the major current environmental
challenges -- global warming, deforestation, water
and air pollution, top-soil erosion, a loss of
biodiversity, and the ‘clear-cutting’ of oceans The
environmental benefit of transitioning to a plantbased diet.

20 mins
Stacey
DunnEmke

40 mins

Mark

10 mins

Total

The importance of fruits & vegetables, whole
grains, supplementing your diet (B12, essential
fatty acids, calcium, iron, & zinc) with foods or
supplements. Questions.

2 hrs, 45 minutes

Materials and Notes: Environmental lecture given by Linda Riebel Ph.D – author of Eating to Save the Earth:
Food Choices for a Healthy Planet, and a psychologist specializing in eating disorders. Handouts will
include sample menus and healthy snack ideas, tips on optimizing calcium, iron and zinc intake.
Homework: Create another different 2 day menu and shopping list.
SESSION 4 GOALS:
Environmental Lecture: Participants should become more aware of the gravity of current environmental
challenges facing our nation and the earth as a whole. They should understand that our consumption
practices, and especially our dietary choices, play a major role in creating and exacerbating these problems.
The basic concept of why eating high on the food chain is inefficient and wasteful should become clear to
participants. Participants should be inspired to use their food choices as a means to support sustainable,
environmentally friendly agriculture. The lecturer will also draw from her experience as a psychologist
specializing in eating disorders to help participants integrate the knowledge they have been exposed to into
their own framework for making food choices. The importance of a ‘continuum of choices’ model vs. an
‘either-or’ model will be emphasized.
Vegan Nutrition Lecture: This talk should reinforce the value of eating more whole, unprocessed plantfoods in replace of processed/refined foods. Nutritional issues that participants should be aware of – like
how to get sufficient calcium/iron/B12/zinc – should be explained. Nutritional issues that often confuse
patients and prevent patients from adopting a plant-based diet (e.g. the notion that meat and dairy are
essential to good health) should also be clarified or reinforced. The value of taking a daily multivitamin
(which includes vitamin B12) should also be reinforced.
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Session 5. Where your food comes from – intensive confinement practices, factory farms and
the treatment of food-animals
Part 1. Group Check-in

Mark,
Dr.
Marlin
Break

Part 2. Comparative Animal Biology

20 mins

Early experiences, questions& concerns,
homework review.

10 mins
Mark

Dinner Break

40 mins

This lecture provides background material
necessary for the intensive-confinement farming
lecture. Topics covered include: evolutionary
human biology; comparative anatomy &
physiology between carnivores, omnivores and
herbivores; emotional lives of other animals

20 mins

Part 3. Intensive Confinement Farming

Mark

40 mins

An overview of modern animal farming techniques
is presenting after a brief discussion on the recent
evolution of these techniques. The scope of
animal agriculture is described followed by a
discussion of how meat, milk, veal, eggs, pork,
chicken & duck is produced in the US.

Part 4. Question, answer & discussion period

Mark

30 mins

Following check-in style responses.

Recap & Homework Overview

Mark

10 mins

Total

2 hrs, 50 minutes

Materials and Notes: The treatment and slaughter of farm animals can be visually disturbing to many
individuals. These presentations aimed to show the minimal amount of content to inform and impact
food choices. Care was taken to present and discuss this material in a sensitive, responsible and nonjudgmental manner. It was emphasized that the purpose of exposing the participants to this material is
to allow them to make more informed food choices, and is not to make them feel guilty about their
choices.
Please see Selected Slides from Session 5, following description of Session 6
Homework: Choose from library or share your knowledge using a video tool (e.g. babe, chicken run, the
witness)
SESSION 5 GOALS:
Animal Biology Lecture: The environment our ancestors evolved in has important implications for our
current dietary requirements. Participants will understand that with the exception of the past century our
ancestors ate a plant-based diet. The important contribution of hunting and animals products to our survival
and social/cultural evolution will be placed in perspective. By comparing the anatomy and physiology of
humans to carnivores, herbivores and omnivores it should become clear that we have evolved primarily to
eat plant-products but like all animals can ingest and digest a wide range of substances of plant and animal
origin. Finally, a discussion of the central nervous system of other animals (focusing on farm animals) along
side an overview of Dr. Jefferey Masson’s work on the emotional lives of animals should convince
participants that all animals live with emotions that can be compared to ours.
Intensive-Confinement Farming Lecture: Participants will gain historical perspective into the creation of
“factory farms” (i.e. intensive confinement operations) and will be introduced to the scale of demand for
animal-products that necessitates their existence. Participants will gain appreciation for the fact that factory
farming accounts for the vast majority of animal agriculture and that small, family farms are becoming
virtually non existent. The consequence of turning livestock into a commodity in the modern world will be
explored throughout the presentation to give participants a framework for digesting the material. A brief
discussion of the lives of each of the major farm animals will be presented, with emphasis on the how they
are raised rather than how they are slaughtered. By becoming more informed about the nature of animal
agriculture in this country, participants should feel more able to make informed and conscious food choices.
The overall goal of this lecture is to provide a non-threatening, non-judgmental and sensitive environment to
enable open discussion of the ethics of raising animals for food.
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Session 6. Fast Food, Food Safety & Public Health
Part 1. Group Check-in

Mark,
Dr.
Marlin
Break

30 mins

10 mins

Part 2. Lecture & discussion: Fast Food,
Food Safety and Food Politics

Michele
Simon

40 mins

Part 3. Question, answer & discussion period.

Michele
Simon

20 mins

Dinner Break
Part 4. Group discussion – Healthy Fast Food
Recap & Homework Overview

Thoughts on session 5, homework review.

An overview of Eric Schlosser’s Fast Food Nation
– an in depth exploration of the fast food industry.
Food borne illnesses, worker conditions,
marketing campaigns, and health consequences
of fast food. Insights into food policy and your role
as a consumer.

20 mins
Mark

40 mins

Practical tips for preparing, buying or ordering
healthy, vegan ‘fast food’.

Mark

10 mins

Overview of Maintenance Sessions

Total

2 hrs, 50 minutes

Materials and Notes: Lecture will be given by Michele Simon, MPH, founder and director of the Center for
Informed Food Choices. Handouts include a guide to understanding ingredient lists and nutrition labels
on foods.
Homework: Create list of topics you would like covered during maintenance sessions
SESSION 6 GOALS:
Fast Food & Food Politics Lecture: By giving participants an overview of topics found in Eric Schlosser’s
Fast Food Nation, participants will gain appreciation for the economic and political forces that shape the
modern dietary environment. Participants will learn about the marketing practices of soda and fast food
companies, working conditions in the fast food industry, food-production techniques and the implications for
food safety and public health. By getting a better understanding of fast food products and the industry which
supports these products, participants will be equipped to make more-informed food choices.
Healthy Fast-Food Group Discussion: Participants will have an opportunity to learn about strategies that
can help them find convenient, quick yet healthy plant-based alternatives to fast-food. Participants should
leave the discussion feeling like many alternatives are available to be explored. They should also have the
opportunity to share their discoveries with other members of the group.

Overview of other intervention components:
Homework: this is an opportunity to reinforce what was learned in the previous session. Homework will be tailored to
the needs of individual participants.
Meals: Light vegan meals will be provided by the GCRC kitchen. This will provide participants incentive to attend
sessions and introduce them to a variety of plant-based dietary options.
Resource Library: This will be a portable collection of videos, nutrition and cook books, audio-tapes, pamphlets
Maintenance Sessions: These will be tailored to the needs of the group participants. 4 Sessions were provided for
each group including a cooking demonstration. Each session lasted 1.5-2 hours.
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Selected Slides from Session 5

Description of Slides: Top from ’animal biology’, middle & bottom from ’intensive-confinement farming’ lecture.
Top left: Comparison of herbivore and carnivore jaw structure. (The ability to move in a horizontal plane allows for chewing (i.e.
of plant-material) but sacrifices power and stability (needed for killing prey).
Top right: Summary slide of Dr. Masson’s When Elephants Weep.
Middle left: Scale of US and Global animal agriculture as described by annual slaughter rates.
Middle right: Intro slide to diary production, showing cows with chronic mastitis and hamburgers (dairy cows
25% US beef)
Bottom left: Intro slide to veal production, a by-product of the dairy industry (veal is from male calves).
Bottom right: Intro slide to pork and bacon production. Pigs are likely the most intensely confined farm animals.
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